Document
P10Yfalse--12-31Q320200001723089us-gaap:AccountingStandardsUpdate201613Member 4267220004953800004000000.010.012500000000250000000077500000199800000775000001998000000.0405400.0050.063750.063750.030.14000P7YP40YP20YP3YP5YP3YP0Y2300000200000 0001723089 2020-01-01 2020-09-30 0001723089 2020-10-26 0001723089 2019-07-01 2019-09-30 0001723089 2020-07-01 2020-09-30 0001723089 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember 2020-01-01 2020-09-30 0001723089 us-gaap:ServiceMember 2019-07-01 2019-09-30 0001723089 us-gaap:ProductMember 2019-07-01 2019-09-30 0001723089 us-gaap:ProductMember 2020-07-01 2020-09-30 0001723089 us-gaap:ServiceMember 2020-01-01 2020-09-30 0001723089 2019-12-31 0001723089 2020-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001723089 us-gaap:RetainedEarningsMember 2019-12-31 0001723089 us-gaap:CommonStockMember 2020-06-30 0001723089 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001723089 us-gaap:RetainedEarningsMember 2020-09-30 0001723089 us-gaap:CommonStockMember 2020-03-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2020-06-30 0001723089 2020-04-01 2020-06-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-12-31 0001723089 us-gaap:CommonStockMember 2019-12-31 0001723089 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001723089 us-gaap:CommonStockMember 2020-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2020-03-31 0001723089 2020-01-01 2020-03-31 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001723089 2020-06-30 0001723089 us-gaap:NoncontrollingInterestMember 2020-09-30 0001723089 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001723089 2020-03-31 0001723089 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001723089 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001723089 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001723089 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001723089 us-gaap:RetainedEarningsMember 2020-03-31 0001723089 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001723089 us-gaap:RetainedEarningsMember 2020-06-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-03-31 0001723089 2019-01-01 2019-03-31 0001723089 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001723089 us-gaap:CommonStockMember 2019-06-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001723089 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001723089 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001723089 2019-04-01 2019-06-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001723089 us-gaap:RetainedEarningsMember 2019-06-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001723089 2019-03-31 0001723089 us-gaap:RetainedEarningsMember 2019-03-31 0001723089 2019-09-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001723089 us-gaap:CommonStockMember 2018-12-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001723089 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001723089 us-gaap:CommonStockMember 2019-03-31 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001723089 us-gaap:CommonStockMember 2019-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-09-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001723089 2019-06-30 0001723089 us-gaap:NoncontrollingInterestMember 2018-12-31 0001723089 us-gaap:RetainedEarningsMember 2018-12-31 0001723089 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-06-30 0001723089 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001723089 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001723089 us-gaap:RetainedEarningsMember 2019-09-30 0001723089 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001723089 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0001723089 2018-12-31 0001723089 us-gaap:ProductMember srt:ScenarioPreviouslyReportedMember 2019-07-01 2019-09-30 0001723089 srt:ScenarioPreviouslyReportedMember 2019-07-01 2019-09-30 0001723089 srt:RestatementAdjustmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember srt:RestatementAdjustmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:ProductMember srt:RestatementAdjustmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember srt:ScenarioPreviouslyReportedMember 2019-07-01 2019-09-30 0001723089 srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-09-30 0001723089 srt:RestatementAdjustmentMember 2019-01-01 2019-09-30 0001723089 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2019-09-30 0001723089 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001723089 srt:RestatementAdjustmentMember 2019-09-30 0001723089 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2019-09-30 0001723089 srt:ScenarioPreviouslyReportedMember 2019-09-30 0001723089 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001723089 us-gaap:SalvageValueMember 2020-01-01 2020-09-30 0001723089 2020-03-31 2020-03-31 0001723089 us-gaap:SalvageValueMember 2020-03-31 0001723089 us-gaap:SalvageValueMember 2020-04-01 0001723089 us-gaap:SalvageValueMember 2020-07-01 2020-09-30 0001723089 2020-04-01 2020-04-01 0001723089 srt:RestatementAdjustmentMember 2018-12-31 0001723089 srt:ScenarioPreviouslyReportedMember 2019-06-30 0001723089 srt:RestatementAdjustmentMember 2019-06-30 0001723089 srt:RestatementAdjustmentMember 2019-03-31 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0001723089 srt:ScenarioPreviouslyReportedMember 2019-03-31 0001723089 srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-03-31 0001723089 srt:ScenarioPreviouslyReportedMember 2018-12-31 0001723089 srt:RestatementAdjustmentMember 2019-04-01 2019-06-30 0001723089 srt:ScenarioPreviouslyReportedMember 2019-04-01 2019-06-30 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember srt:RestatementAdjustmentMember 2018-12-31 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember srt:ScenarioPreviouslyReportedMember 2018-12-31 0001723089 srt:RestatementAdjustmentMember 2019-01-01 2019-03-31 0001723089 us-gaap:ProductMember srt:RestatementAdjustmentMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember srt:RestatementAdjustmentMember 2019-01-01 2019-09-30 0001723089 apy:LegacyChampionXMember apy:FavorableSupplyAgreementMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember 2020-01-01 2020-09-30 0001723089 apy:LegacyChampionXMember 2020-06-03 0001723089 apy:LegacyChampionXMember 2020-06-03 2020-06-30 0001723089 2019-12-18 0001723089 apy:LegacyChampionXMember 2020-07-01 2020-09-30 0001723089 srt:AffiliatedEntityMember 2020-01-01 2020-09-30 0001723089 apy:LegacyChampionXMember 2020-06-03 2020-06-03 0001723089 apy:ChampionXEquityholdersMember apy:LegacyChampionXMember 2020-06-03 0001723089 srt:AffiliatedEntityMember 2020-07-01 2020-09-30 0001723089 apy:LegacyChampionXMember apy:ProductionChemicalTechnologiesMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember apy:ReservoirChemicalTechnologiesMember 2020-06-03 2020-06-03 0001723089 apy:EquityholdersPriorToMergerMember apy:LegacyChampionXMember 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:DevelopedTechnologyRightsMember 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:TrademarksAndTradeNamesMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember apy:FavorableSupplyAgreementMember 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:DevelopedTechnologyRightsMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:CustomerRelationshipsMember 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:CustomerRelationshipsMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:TrademarksAndTradeNamesMember 2020-06-03 0001723089 apy:LegacyChampionXMember 2019-07-01 2019-09-30 0001723089 apy:LegacyChampionXMember 2019-01-01 2019-09-30 0001723089 apy:EcolabMember apy:LegacyChampionXMember 2020-06-03 2020-06-03 0001723089 2019-12-18 2019-12-18 0001723089 srt:MaximumMember apy:LegacyChampionXMember us-gaap:MachineryAndEquipmentMember 2020-06-03 2020-06-03 0001723089 srt:MinimumMember apy:LegacyChampionXMember us-gaap:BuildingAndBuildingImprovementsMember 2020-06-03 2020-06-03 0001723089 apy:LegacyChampionXMember us-gaap:LandAndLandImprovementsMember 2020-06-03 2020-06-03 0001723089 srt:MaximumMember apy:LegacyChampionXMember us-gaap:BuildingAndBuildingImprovementsMember 2020-06-03 2020-06-03 0001723089 srt:MinimumMember apy:LegacyChampionXMember us-gaap:MachineryAndEquipmentMember 2020-06-03 2020-06-03 0001723089 srt:MinimumMember apy:LegacyChampionXMember apy:CapitalizedSoftwareAndComputerHardwareMember 2020-06-03 2020-06-03 0001723089 srt:MaximumMember apy:LegacyChampionXMember apy:CapitalizedSoftwareAndComputerHardwareMember 2020-06-03 2020-06-03 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0001723089 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 2020-01-01 0001723089 2020-01-01 2020-01-01 0001723089 apy:ProductionandAutomationTechnologiesMember apy:ArtificialLiftMember 2020-01-01 2020-03-31 0001723089 apy:ProductionandAutomationTechnologiesMember apy:AutomationTechnologiesMember 2020-01-01 2020-03-31 0001723089 us-gaap:TrademarksMember apy:ArtificialLiftMember 2020-01-01 2020-03-31 0001723089 us-gaap:MeasurementInputDiscountRateMember apy:ArtificialLiftMember 2020-09-30 0001723089 us-gaap:MeasurementInputDiscountRateMember apy:AutomationTechnologiesMember 2020-09-30 0001723089 us-gaap:CustomerRelationshipsMember apy:ArtificialLiftMember 2020-01-01 2020-03-31 0001723089 apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:ReservoirChemicalTechnologiesMember 2019-12-31 0001723089 apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:ProductionChemicalTechnologiesMember 2020-09-30 0001723089 apy:DrillingTechnologiesMember 2020-09-30 0001723089 apy:ProductionandAutomationTechnologiesMember 2019-12-31 0001723089 apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:ProductionandAutomationTechnologiesMember 2020-09-30 0001723089 apy:ReservoirChemicalTechnologiesMember 2020-09-30 0001723089 apy:DrillingTechnologiesMember 2019-12-31 0001723089 apy:ProductionChemicalTechnologiesMember 2019-12-31 0001723089 us-gaap:CustomerRelationshipsMember 2019-12-31 0001723089 us-gaap:CustomerRelationshipsMember 2020-09-30 0001723089 us-gaap:UnpatentedTechnologyMember 2019-12-31 0001723089 us-gaap:TrademarksMember 2019-12-31 0001723089 apy:DrawingsAndManualsMember 2020-09-30 0001723089 us-gaap:OtherIntangibleAssetsMember 2020-09-30 0001723089 us-gaap:TrademarksMember 2020-09-30 0001723089 us-gaap:PatentsMember 2020-09-30 0001723089 apy:FavorableSupplyAgreementMember 2019-12-31 0001723089 us-gaap:UnpatentedTechnologyMember 2020-09-30 0001723089 apy:DrawingsAndManualsMember 2019-12-31 0001723089 us-gaap:TrademarksMember 2020-09-30 0001723089 us-gaap:TrademarksMember 2019-12-31 0001723089 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0001723089 apy:FavorableSupplyAgreementMember 2020-09-30 0001723089 us-gaap:PatentsMember 2019-12-31 0001723089 apy:A2020TermLoanFacilityMember 2020-09-30 0001723089 apy:A2018CreditFacilityMember apy:TermLoanFacilityMember 2020-02-14 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember 2020-06-03 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-06-03 2020-06-03 0001723089 srt:MaximumMember apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-06-03 2020-06-03 0001723089 srt:MinimumMember apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-06-03 2020-06-03 0001723089 2020-06-03 2020-06-03 0001723089 apy:A2018CreditFacilityMember us-gaap:LineOfCreditMember 2020-02-14 0001723089 apy:A2018CreditFacilityMember 2020-09-30 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember apy:EurocurrencyMarginalRateMember 2020-06-03 2020-06-03 0001723089 apy:A2018TermLoanFacilityMember apy:TermLoanFacilityMember 2020-09-30 0001723089 apy:A6.375SeniorNotesDueMay2026Member us-gaap:SeniorNotesMember 2020-09-30 0001723089 us-gaap:LineOfCreditMember 2019-12-31 0001723089 apy:A2018TermLoanFacilityMember apy:TermLoanFacilityMember 2019-12-31 0001723089 apy:A6.375SeniorNotesDueMay2026Member us-gaap:SeniorNotesMember 2019-12-31 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember 2019-12-31 0001723089 us-gaap:LineOfCreditMember 2020-09-30 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember 2020-09-30 0001723089 apy:A2020TermLoanFacilityMember apy:TermLoanFacilityMember apy:FederalFundsRateMember 2020-06-03 2020-06-03 0001723089 us-gaap:IndemnificationGuaranteeMember 2019-12-31 0001723089 us-gaap:IndemnificationGuaranteeMember 2020-04-01 2020-04-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-03-31 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-04-01 2019-06-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-04-01 2019-06-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-07-01 2019-09-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-01-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-01-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-07-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-07-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-04-01 2020-06-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-01 2020-06-30 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-06-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0001723089 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001723089 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-09-30 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001723089 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0001723089 srt:AsiaPacificMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember apy:OtherMember 2019-01-01 2019-09-30 0001723089 apy:OtherMember 2019-01-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 apy:OtherMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:AU 2019-01-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:CA 2019-01-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:CA apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:US 2019-01-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:AU apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:US apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:US apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:EuropeMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:LatinAmericaMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-30 0001723089 country:US apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 apy:OtherMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 apy:OtherMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:LatinAmericaMember 2019-01-01 2019-09-30 0001723089 country:US apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:CA apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:AU 2019-01-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:MiddleEastMember 2019-01-01 2019-09-30 0001723089 srt:AsiaPacificMember 2019-01-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 apy:OtherMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:EuropeMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:AU apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:AU apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:AsiaPacificMember 2019-01-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:CA apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:EuropeMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:MiddleEastMember 2019-01-01 2019-09-30 0001723089 country:AU apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:CA 2019-01-01 2019-09-30 0001723089 srt:EuropeMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:CA apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 country:US 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:EuropeMember 2019-01-01 2019-09-30 0001723089 srt:EuropeMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 srt:EuropeMember 2020-01-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:OtherMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:AU 2020-01-01 2020-09-30 0001723089 country:CA apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:EuropeMember 2020-01-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember apy:OtherMember 2020-01-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:CA 2020-01-01 2020-09-30 0001723089 apy:OtherMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:US 2020-01-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:EuropeMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:CA apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:AU apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:US apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:AU apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:AU apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:LatinAmericaMember 2020-01-01 2020-09-30 0001723089 country:US apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:MiddleEastMember 2020-01-01 2020-09-30 0001723089 country:AU apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:AsiaPacificMember 2020-01-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:EuropeMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:US apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:EuropeMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:MiddleEastMember 2020-01-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:OtherMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0001723089 country:CA apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:US 2020-01-01 2020-09-30 0001723089 country:US apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:OtherMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:LatinAmericaMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:CA 2020-01-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:OtherMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:AU 2020-01-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 srt:EuropeMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 country:CA apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:EuropeMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:AsiaPacificMember 2020-07-01 2020-09-30 0001723089 country:AU apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:LatinAmericaMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:US 2020-07-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember 2020-07-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 apy:OtherMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 apy:OtherMember 2020-07-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:CA apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 apy:OtherMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:CA 2020-07-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:AU apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:AU apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 apy:OtherMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:EuropeMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:US apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:US 2020-07-01 2020-09-30 0001723089 country:CA apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:CA apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:AU 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember apy:OtherMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:MiddleEastMember 2020-07-01 2020-09-30 0001723089 country:CA apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:US apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:EuropeMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:US apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:LatinAmericaMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:LatinAmericaMember 2020-07-01 2020-09-30 0001723089 apy:OtherMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:EuropeMember 2020-07-01 2020-09-30 0001723089 country:CA 2020-07-01 2020-09-30 0001723089 country:AU apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:AU 2020-07-01 2020-09-30 0001723089 srt:AsiaPacificMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 country:US apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:EuropeMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 srt:EuropeMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:MiddleEastMember 2020-07-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:LatinAmericaMember 2019-07-01 2019-09-30 0001723089 srt:EuropeMember 2019-07-01 2019-09-30 0001723089 srt:AsiaPacificMember 2019-07-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:US apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:LatinAmericaMember 2019-07-01 2019-09-30 0001723089 country:CA apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:AsiaPacificMember 2019-07-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:CA 2019-07-01 2019-09-30 0001723089 apy:OtherMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:MiddleEastMember 2019-07-01 2019-09-30 0001723089 country:US apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:EuropeMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:CA apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:AU apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:AU apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:AU 2019-07-01 2019-09-30 0001723089 srt:EuropeMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:EuropeMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:US apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:MiddleEastMember 2019-07-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:AU 2019-07-01 2019-09-30 0001723089 country:AU apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:CA apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:AU apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember apy:OtherMember 2019-07-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:US 2019-07-01 2019-09-30 0001723089 apy:OtherMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:CA apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 apy:OtherMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 apy:OtherMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember country:CA 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember 2019-07-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember srt:EuropeMember 2019-07-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:AsiaPacificMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 apy:OtherMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:US 2019-07-01 2019-09-30 0001723089 srt:LatinAmericaMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 country:US apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:MiddleEastMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 srt:EuropeMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ProductMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ServiceMember 2020-01-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 apy:ProductionChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ServiceMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ProductMember 2020-01-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ProductionChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 apy:ProductionandAutomationTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ProductMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ProductionandAutomationTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ProductMember 2019-01-01 2019-09-30 0001723089 apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ServiceMember 2019-07-01 2019-09-30 0001723089 apy:ProductionandAutomationTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ServiceMember 2020-07-01 2020-09-30 0001723089 apy:ProductionChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember apy:DrillingTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ProductMember apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:CorporateNonSegmentMember us-gaap:ProductMember 2020-07-01 2020-09-30 0001723089 us-gaap:ServiceMember apy:ProductionandAutomationTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:ProductMember apy:ProductionChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:ServiceMember apy:ReservoirChemicalTechnologiesMember 2020-01-01 2020-09-30 0001723089 us-gaap:ProductMember apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001723089 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001723089 apy:DrillingTechnologiesMember 2019-07-01 2019-09-30 0001723089 apy:ReservoirChemicalTechnologiesMember 2019-01-01 2019-09-30 0001723089 apy:ReservoirChemicalTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001723089 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001723089 apy:DrillingTechnologiesMember 2020-07-01 2020-09-30 0001723089 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0001723089 apy:ReservoirChemicalTechnologiesMember 2019-07-01 2019-09-30 0001723089 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0001723089 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-09-30 0001723089 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001723089 apy:DrillingTechnologiesMember 2019-01-01 2019-09-30 0001723089 us-gaap:StockAppreciationRightsSARSMember 2019-12-31 0001723089 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001723089 apy:NonQualifiedStockOptionsMember 2020-01-01 2020-09-30 0001723089 us-gaap:StockAppreciationRightsSARSMember 2020-01-01 2020-09-30 0001723089 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001723089 apy:NonQualifiedStockOptionsMember 2019-12-31 0001723089 us-gaap:PerformanceSharesMember 2020-09-30 0001723089 us-gaap:PerformanceSharesMember 2019-12-31 0001723089 us-gaap:StockAppreciationRightsSARSMember 2020-09-30 0001723089 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0001723089 us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0001723089 apy:NonQualifiedStockOptionsMember 2020-09-30 0001723089 apy:A2020TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member apy:TermLoanFacilityMember 2020-09-30 0001723089 apy:A2018TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member apy:TermLoanFacilityMember 2019-12-31 0001723089 apy:A2020TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member apy:TermLoanFacilityMember 2019-12-31 0001723089 apy:A6.375SeniorNotesDueMay2026Member us-gaap:FairValueInputsLevel1Member us-gaap:SeniorNotesMember 2020-09-30 0001723089 apy:A2018TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member apy:TermLoanFacilityMember 2020-09-30 0001723089 apy:A6.375SeniorNotesDueMay2026Member us-gaap:FairValueInputsLevel1Member us-gaap:SeniorNotesMember 2019-12-31 0001723089 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001723089 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001723089 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001723089 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001723089 us-gaap:OtherCurrentLiabilitiesMember 2020-09-30 0001723089 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-09-30 0001723089 us-gaap:ForeignExchangeForwardMember 2019-12-31 0001723089 us-gaap:ForeignExchangeForwardMember 2020-09-30 0001723089 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember 2019-01-01 2019-09-30 0001723089 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember 2019-07-01 2019-09-30 0001723089 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001723089 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001723089 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001723089 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001723089 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember 2020-07-01 2020-09-30 0001723089 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember 2020-01-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember 2019-01-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001723089 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001723089 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001723089 us-gaap:AssetsLeasedToOthersMember 2019-01-01 2019-09-30 0001723089 us-gaap:AssetsLeasedToOthersMember 2020-01-01 2020-09-30 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares utreg:kg apy:location
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File Number: 001-38441
ChampionX Corporation
(Exact name of registrant as specified in its charter)
Delaware
82-3066826
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
 
2445 Technology Forest Blvd,
Building 4, 12th Floor
 
The Woodlands,
Texas
77381
(Address of principal executive offices)
(Zip Code)
(281) 403-5772
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
CHX
New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
Accelerated filer
Non-accelerated filer
 
Smaller reporting company
 
 
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

The registrant had 199,833,331 shares of common stock, $0.01 par value, outstanding as of October 26, 2020.



CHAMPIONX CORPORATION

TABLE OF CONTENTS

Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 






CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements usually relate to future events and anticipated revenues, earnings, cash flows or other aspects of our operations or operating results. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking statements. Forward-looking statements are based on our current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.

All of our forward-looking statements involve risks, uncertainties (some of which are significant or beyond our control) and assumptions that could cause actual results to materially differ from our historical experience and our present expectations or projections. Known material factors that could cause actual results to materially differ from those contemplated in the forward-looking statements are those set forth in Part II, Item 1A, “Risk Factors” of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020.

We wish to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.



PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in thousands, except per share data)
2020
 
2019
 
2020
 
2019
Product revenue
$
540,825

 
$
239,867

 
$
1,014,140

 
$
775,489

Service revenue
76,665

 
23,979

 
138,436

 
71,853

Lease and other revenue
16,036

 
12,993

 
41,298

 
36,161

Total revenue
633,526

 
276,839

 
1,193,874

 
883,503

Cost of goods and services
505,066

 
184,140

 
950,845

 
579,033

Gross profit
128,460

 
92,699

 
243,029

 
304,470

Selling, general and administrative expense
122,156

 
68,405

 
330,956

 
199,221

Goodwill impairment

 

 
616,271

 

Long-lived asset impairment

 

 
40,980

 
1,746

Interest expense, net
15,935

 
9,590

 
36,236

 
30,226

Other (income) expense, net
1,663

 
(309
)
 
342

 
3,469

Income (loss) before income taxes
(11,294
)
 
15,013

 
(781,756
)
 
69,808

Provision for (benefit from) income taxes
(3,962
)
 
3,425

 
(31,922
)
 
15,274

Net income (loss)
(7,332
)
 
11,588

 
(749,834
)
 
54,534

Less: Net income attributable to noncontrolling interest
582

 
194

 
1,453

 
547

Net income (loss) attributable to ChampionX
$
(7,914
)
 
$
11,394

 
$
(751,287
)
 
$
53,987

 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to ChampionX:
 
 
 
 
 
 
 
Basic
$
(0.04
)
 
$
0.15

 
$
(5.73
)
 
$
0.70

Diluted
$
(0.04
)
 
$
0.15

 
$
(5.73
)
 
$
0.70

Weighted-average shares outstanding:
 
 
 
 
 
 
 
Basic
199,809

 
77,460

 
131,064

 
77,416

Diluted
199,809

 
77,573

 
131,064

 
77,615



The accompanying notes are an integral part of the condensed consolidated financial statements.

1


CHAMPIONX CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Net income (loss)
$
(7,332
)
 
$
11,588

 
$
(749,834
)
 
$
54,534

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
Foreign currency translation adjustments (1)
3,782

 
(2,900
)
 
(1,567
)
 
(836
)
Cash flow hedges
(862
)
 

 
(209
)
 

Defined pension and other post-retirement benefits adjustments, net(2)
99

 
68

 
297

 
235

Other comprehensive income (loss)
3,019

 
(2,832
)
 
(1,479
)
 
(601
)
Comprehensive income (loss)
(4,313
)
 
8,756

 
(751,313
)
 
53,933

Comprehensive income attributable to noncontrolling interest
582

 
194

 
1,453

 
547

Comprehensive income (loss) attributable to ChampionX
$
(4,895
)
 
$
8,562

 
$
(752,766
)
 
$
53,386

_______________________
(1) Net of income tax (expense) benefit of $0 for the three and nine months ended September 30, 2020 and 2019.
(2) Net of income tax (expense) benefit of $33 and $23 for the three months ended September 30, 2020 and 2019, respectively, and $99 and $202 for the nine months ended September 30, 2020 and 2019, respectively.


The accompanying notes are an integral part of the condensed consolidated financial statements.

2


CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
September 30, 2020
 
December 31, 2019
Assets
 
 
 
Cash and cash equivalents
$
171,462

 
$
35,290

Receivables, net
516,245

 
219,874

Inventories, net
471,331

 
211,342

Prepaid expenses and other current assets
73,713

 
26,934

Total current assets
1,232,751

 
493,440

Property, plant and equipment, net of accumulated depreciation of $495,380 in 2020 and $426,722 in 2019
868,111

 
248,181

Operating lease right-of-use assets
118,993

 
24,289

Goodwill
660,329

 
911,113

Intangible assets, net
509,789

 
238,707

Other non-current assets
63,759

 
7,095

Total assets
$
3,453,732

 
$
1,922,825

Liabilities and Equity
 
 
 
Current portion of long-term debt
$
31,470

 
$
4,845

Accounts payable
262,092

 
120,291

Accrued compensation and employee benefits
60,566

 
38,470

Current portion of operating lease liabilities
33,888

 
7,620

Accrued distributor fees
36,386

 

Accrued expenses and other current liabilities
150,005

 
28,455

Total current liabilities
574,407

 
199,681

Long-term debt
989,690

 
559,821

Deferred income taxes
141,047

 
84,060

Operating lease liabilities
80,261

 
19,419

Other long-term liabilities
82,295

 
23,630

Total liabilities
1,867,700

 
886,611

Stockholders’ equity:
 

 
 
Common stock (2.5 billion shares authorized, $0.01 par value)
199.8 million shares and 77.5 million shares issued and outstanding in 2020 and 2019, respectively
1,998

 
775

Capital in excess of par value of common stock
2,288,930

 
969,174

Retained earnings (accumulated deficit)
(645,863
)
 
107,048

Accumulated other comprehensive loss
(45,516
)
 
(44,037
)
Total stockholders’ equity
1,599,549

 
1,032,960

Noncontrolling interest
(13,517
)
 
3,254

Total equity
1,586,032

 
1,036,214

Total liabilities and equity
$
3,453,732

 
$
1,922,825


The accompanying notes are an integral part of the condensed consolidated financial statements.

3


CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)

 
Common stock
 
 
 
 
 
 
 
 
(in thousands)
Shares
 
Par
Value
 
Capital in Excess of Par Value
 
Retained Earnings (Accum. Deficit)
 
Accum.
Other
Comp.
Loss
 
Non-controlling Interest
 
Total
December 31, 2019
77,460

 
$
775

 
$
969,174

 
$
107,048

 
$
(44,037
)
 
$
3,254

 
$
1,036,214

Cumulative effect of accounting changes, net of tax (Note 3)

 

 

 
(1,573
)
 

 

 
(1,573
)
Net income (loss)

 

 

 
(633,728
)
 

 
273

 
(633,455
)
Other comprehensive loss

 

 

 

 
(10,953
)
 

 
(10,953
)
Stock-based compensation
44

 

 
2,429

 

 

 

 
2,429

Taxes withheld on issuance of stock-based awards

 

 
(368
)
 

 

 

 
(368
)
March 31, 2020
77,504

 
$
775

 
$
971,235

 
$
(528,253
)
 
$
(54,990
)
 
$
3,527

 
$
392,294

Issuance of common stock related to the Merger
122,237

 
1,223

 
1,262,708

 

 

 

 
1,263,931

Issuance of replacement awards related to the Merger

 

 
43,964

 

 

 

 
43,964

Non-controlling interest acquired in the Merger

 

 

 

 

 
(16,015
)
 
(16,015
)
Net income (loss)

 

 

 
(109,645
)
 

 
598

 
(109,047
)
Other comprehensive income

 

 

 

 
6,455

 

 
6,455

Stock-based compensation
67

 

 
5,433

 

 

 

 
5,433

Taxes withheld on issuance of stock-based awards

 

 
(244
)
 

 

 

 
(244
)
Distributions to noncontrolling interest

 

 

 

 

 
(2,200
)
 
(2,200
)
Other

 

 

 
37

 

 
(12
)
 
25

June 30, 2020
199,808

 
$
1,998

 
$
2,283,096

 
$
(637,861
)
 
$
(48,535
)
 
$
(14,102
)
 
$
1,584,596

Net income (loss)

 

 

 
(7,914
)
 

 
582

 
(7,332
)
Other comprehensive income

 

 

 

 
3,019

 

 
3,019

Stock-based compensation
12

 

 
5,856

 

 

 

 
5,856

Taxes withheld on issuance of stock-based awards

 

 
(28
)
 

 

 

 
(28
)
Other

 

 
6

 
(88
)
 

 
3

 
(79
)
September 30, 2020
199,820

 
$
1,998

 
$
2,288,930

 
$
(645,863
)
 
$
(45,516
)
 
$
(13,517
)
 
$
1,586,032



4


 
Common Stock
 
 
 
 
 
 
 
 
(in thousands)
Shares
 
Par
Value
 
Capital in Excess of Par Value
 
Retained Earnings
 
Accum.
Other
Comp.
Loss
 
Non-controlling Interest
 
Total
December 31, 2018
77,353

 
$
774

 
$
960,773

 
$
54,884

 
$
(42,906
)
 
$
2,458

 
$
975,983

Net income

 

 

 
19,656

 

 
282

 
19,938

Other comprehensive income

 

 

 

 
1,189

 

 
1,189

Stock-based compensation
39

 

 
2,285

 

 

 

 
2,285

Taxes withheld on issuance of stock-based awards

 

 
(719
)
 

 

 

 
(719
)
Other

 

 

 

 

 
14

 
14

March 31, 2019
77,392

 
$
774

 
$
962,339

 
$
74,540

 
$
(41,717
)
 
$
2,754

 
$
998,690

Net income

 

 

 
22,937

 

 
71

 
23,008

Other comprehensive income

 

 

 

 
1,042

 

 
1,042

Stock-based compensation
67

 
1

 
2,735

 

 

 

 
2,736

Taxes withheld on issuance of stock-based awards

 

 
(1,080
)
 

 

 

 
(1,080
)
Other

 

 

 

 

 
(14
)
 
(14
)
June 30, 2019
77,459

 
$
775

 
$
963,994

 
$
97,477

 
$
(40,675
)
 
$
2,811

 
$
1,024,382

Net income

 

 

 
11,394

 

 
194

 
11,588

Other comprehensive loss

 

 

 

 
(2,832
)
 

 
(2,832
)
Stock-based compensation

 

 
2,524

 

 

 

 
2,524

Other

 

 
(42
)
 

 

 


 
(42
)
September 30, 2019
77,459

 
$
775

 
$
966,476

 
$
108,871

 
$
(43,507
)
 
$
3,005

 
$
1,035,620


The accompanying notes are an integral part of the condensed consolidated financial statements.



5


CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
Nine Months Ended
September 30,
(in thousands)
2020
 
2019
Cash provided by (used for) operating activities:
 
 
 
Net income (loss)
$
(749,834
)
 
$
54,534

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
101,434

 
51,126

Amortization
47,827

 
38,504

Stock-based compensation
13,718

 
7,545

Loss (gain) on disposal of fixed assets
3,685

 
(846
)
Loss on goodwill and long-lived asset impairment
657,251

 
1,746

Loss on sale of business

 
2,475

Provision for losses on accounts receivable
2,945

 
122

Provision for inventory obsolescence and write-downs
15,626

 
(997
)
Amortization of deferred loan costs and accretion of discount
2,480

 
1,943

Deferred income taxes
(34,318
)
 
(4,439
)
Employee benefit plan expense
1,606

 
1,506

Other
(1,696
)
 
386

Changes in operating assets and liabilities (net of effects of foreign exchange):
 
 
 
Receivables
91,204

 
14,133

Inventories
62,225

 
13,232

Prepaid expenses and other current assets
17,737

 
(16,270
)
Accounts payable
(48,519
)
 
(16,861
)
Accrued compensation and employee benefits
1,518

 
(3,651
)
Accrued expenses and other liabilities
12,846

 
14,121

Leased assets
(7,799
)
 
(34,305
)
Other
(504
)
 
(614
)
Net cash provided by operating activities
189,432

 
123,390

 
 
 
 
Cash provided by (used for) investing activities:
 

 
 

Capital expenditures
(32,169
)
 
(31,589
)
Acquisitions, net of cash acquired
57,588

 
(12,500
)
Proceeds from sale of fixed assets
9,295

 
2,954

Payment on sale of business

 
(2,194
)
Net cash provided by (used for) investing activities
34,714

 
(43,329
)
 
 
 
 
Cash provided by (used for) financing activities:
 

 
 

Proceeds from long-term debt
125,000

 
36,500

Payment of debt issue costs
(4,356
)
 

Repayment of long-term debt
(206,713
)
 
(111,500
)
Distribution to noncontrolling interest
(2,200
)
 

Payment of finance lease obligations
(4,536
)
 
(4,108
)
Payments related to taxes withheld on stock-based compensation
(640
)
 
(1,841
)
Net cash used for financing activities
(93,445
)
 
(80,949
)
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents
5,471

 
(317
)
 
 
 
 
Net increase (decrease) in cash and cash equivalents
136,172

 
(1,205
)
Cash and cash equivalents at beginning of period
35,290

 
41,832

Cash and cash equivalents at end of period
$
171,462

 
$
40,627

The accompanying notes are an integral part of the condensed consolidated financial statements.

6


CHAMPIONX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

NOTE 1—BASIS OF PRESENTATION

ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely and efficiently around the world.

Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires.

On June 3, 2020, the Company and Ecolab Inc. (“Ecolab”) completed a Reverse Morris Trust transaction in which Ecolab transferred their upstream energy business to Champion X Holding, Inc. (“legacy ChampionX”) and, thereafter, distributed all of the shares of legacy ChampionX common stock to certain Ecolab stockholders (“the Distribution”). Immediately following the Distribution, a wholly owned subsidiary of the Company merged with and into legacy ChampionX, with legacy ChampionX continuing as the surviving company in the Merger and as a wholly owned subsidiary of the Company (“the Merger”). In association with the completion of the Merger, the Company has changed its name from Apergy Corporation (“Apergy”) to ChampionX Corporation, and common shares began trading on the New York Stock Exchange under the symbol “CHX”.

As a result of the Merger, the results of operations of legacy ChampionX have been reflected in our accompanying condensed consolidated financial statements from the closing date of the Merger through September 30, 2020. Results for the periods prior to June 3, 2020 reflect the financial and operating results of Apergy and do not include the financial and operating results of legacy ChampionX. See Note 2—Merger Transaction for additional information on the Merger.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the year ended December 31, 2019.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2020.

Change in Accounting Estimate

During the second quarter, we entered into new commercial agreements, which changed the economics of the leased asset program of our Electrical Submersible Pump (“ESP”) subsidiary in our Production & Automation Technologies segment. As such, we re-evaluated the estimated useful life and salvage value of our assets based on the combination of new commercial contracts and historical operating trends related to the aging of our lease fleet, including functioning assets beyond original expected life. Based on our analysis, effective April 1, 2020, we changed our estimate of useful life and salvage values for certain equipment to better reflect the useful life and estimated values of these assets at the end of their useful life. The estimated useful life, previously estimated at 12 months, was increased to 18 months. The estimated salvage value of the equipment, previously estimated at 50%, was decreased to 0%. The effect of the changes in estimate for the three and nine months ended September 30, 2020, was an increase in depreciation expense of $8.6 million and $26.2 million, respectively, a decrease in net income of $5.7 million and $17.6 million, and a decrease in basic and diluted earnings per share of $0.03 per share and $0.13 per share, respectively.

7



Reclassifications

Certain prior period amounts have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss.

Revisions

We revised our previously issued financial statements for the three and nine months ended September 30, 2019, for the correction of immaterial errors related to: (i) the assessing and recording of liabilities for state sales tax and associated penalties and interest, primarily resulting in an understatement of our selling, general, and administrative expense and interest expense for the three and nine months ended September 30, 2019; and (ii) previously recorded amounts including, but not limited to, the write-off of inventory and leased assets, timing of revenue recognition, and revenue classification, that the Company concluded were immaterial to our previously filed condensed consolidated financial statements. See the following table for the impact of the corrections on our condensed consolidated financial statements:

Condensed Consolidated Statement of Income
 
Three Months Ended
September 30, 2019
(in thousands, except per share data)
As Reported
 
Adjustments
 
As Revised
Product revenue (1)
$
244,651

 
$
(4,784
)
 
$
239,867

Service revenue (1)
20,708

 
3,271

 
23,979

Lease and other revenue (1)
13,022

 
(29
)
 
12,993

Total revenue
278,381

 
(1,542
)
 
276,839

Cost of goods and services
186,862

 
(2,722
)
 
184,140

Gross profit
91,519

 
1,180

 
92,699

Selling, general and administrative expense
68,813

 
(408
)
 
68,405

Interest expense, net
9,537

 
53

 
9,590

Income before income taxes
13,478

 
1,535

 
15,013

Provision for income taxes
3,059

 
366

 
3,425

Net income
10,419

 
1,169

 
11,588

Net income attributable to ChampionX
$
10,225

 
$
1,169

 
$
11,394

 
 
 
 
 
 
Earnings per share attributable to ChampionX:
 
 
 
 
 
Basic
$
0.13

 
$
0.02

 
$
0.15

Diluted
$
0.13

 
$
0.02

 
$
0.15

 
 
 
 
 
 
Comprehensive income
$
7,587

 
$
1,169

 
$
8,756

Comprehensive income attributable to ChampionX
$
7,393

 
$
1,169

 
$
8,562


(1) Certain as reported amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported net income (loss).



8


 
Nine Months Ended
September 30, 2019
(in thousands, except per share data)
As Reported
 
Adjustments
 
As Revised
Product revenue (1)
$
787,698

 
$
(12,209
)
 
$
775,489

Service revenue (1)
62,056

 
9,797

 
71,853

Lease and other revenue (1)
36,372

 
(211
)
 
36,161

Total revenue
886,126

 
(2,623
)
 
883,503

Cost of goods and services
579,289

 
(256
)
 
579,033

Gross profit
306,837

 
(2,367
)
 
304,470

Selling, general and administrative expense
199,044

 
177

 
199,221

Long-lived asset impairment (1)
1,746

 

 
1,746

Interest expense, net
30,068

 
158

 
30,226

Income before income taxes
72,510

 
(2,702
)
 
69,808

Provision for income taxes
15,672

 
(398
)
 
15,274

Net income
56,838

 
(2,304
)
 
54,534

Net income attributable to ChampionX
$
56,291

 
$
(2,304
)
 
$
53,987

 
 
 
 
 
 
Earnings per share attributable to ChampionX:
 
 
 
 
 
Basic
$
0.73

 
$
(0.03
)
 
$
0.70

Diluted
$
0.73

 
$
(0.03
)
 
$
0.70

 
 
 
 
 
 
Comprehensive income
$
56,237

 
(2,304
)
 
$
53,933

Comprehensive income attributable to ChampionX
$
55,690

 
(2,304
)
 
$
53,386



(1) Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported net income (loss).
Condensed Consolidated Statement of Changes in Stockholders’ Equity
 
September 30, 2019
(in thousands)
As Reported
 
Adjustments
 
As Revised
Stockholders’ Equity:
 
 
 
 

Capital in excess of par value of common stock
$
971,075

 
$
(4,599
)
 
$
966,476

Retained earnings
110,458

 
(1,587
)
 
108,871

Total equity
1,041,806

 
(6,186
)
 
1,035,620


(in thousands)
As Reported
 
Adjustments
 
As Revised
Total equity at December 31, 2018
$
981,527

 
$
(5,544
)
 
$
975,983

Cumulative effect of accounting changes
(1,662
)
 
1,662

 

Net income
22,569

 
(2,631
)
 
19,938

Total equity at March 31, 2019
1,005,203

 
(6,513
)
 
998,690

Net income
23,850

 
(842
)
 
23,008

Total equity at June 30, 2019
1,031,737

 
(7,355
)
 
1,024,382

Net income
10,419

 
1,169

 
11,588

September 30, 2019
1,041,806

 
(6,186
)
 
1,035,620




9


Condensed Consolidated Statements of Cash Flows
 
Nine Months Ended September 30, 2019
(in thousands)
As Reported
 
Adjustments
 
As Revised
Cash provided by (used for) operating activities:
 
 
 
 
 
Net income
$
56,838

 
$
(2,304
)
 
$
54,534

Adjustments to reconcile net income to net cash provided (required) by operating activities:
 
 
 
 
 
Deferred income taxes
(3,717
)
 
(722
)
 
(4,439
)
Gain on sale of fixed assets (1)
(846
)
 

 
(846
)
Provision for losses on accounts receivable (1)
122

 

 
122

Amortization of deferred loan costs and accretion of discount (1)
1,943

 

 
1,943

Other
386

 

 
386

Changes in operating assets and liabilities (net of effects of foreign exchange):
 
 
 
 
 
Receivables
12,218

 
1,915

 
14,133

Inventories
11,455

 
1,777

 
13,232

Prepaid expenses and other current assets
(16,742
)
 
472

 
(16,270
)
Accounts payable
(15,532
)
 
(1,329
)
 
(16,861
)
Accrued compensation and employee benefits
(3,651
)
 

 
(3,651
)
Accrued expenses and other liabilities
14,288

 
(167
)
 
14,121

Leased assets
(34,645
)
 
340

 
(34,305
)
Other
(634
)
 
20

 
(614
)
_______________________
(1) Each of these amounts were included within other on the condensed consolidated statements of cash flows reported for the nine months ended September 30, 2019. These amounts have been reclassified consistent with the presentation in the current reporting period.

NOTE 2—MERGER TRANSACTION

On June 3, 2020 we completed the acquisition of the legacy ChampionX business through the merger of one of our wholly owned subsidiaries with legacy ChampionX. Immediately prior to the Merger, Ecolab transferred their upstream energy business to legacy ChampionX. Pursuant to the Merger, shares of Ecolab common stock that were tendered through an exchange offer were converted into common shares of legacy ChampionX on a 1-for-24.6667 basis, with each share of legacy ChampionX automatically converting into one share of the Company. To complete the acquisition, we issued 122.2 million shares of common stock, at a share price of $10.34 per share, in exchange for 100% equity ownership of legacy ChampionX. The transaction resulted in legacy ChampionX equityholders owning approximately 62% of the Company on a fully diluted basis, with equityholders of the Company prior to the Merger owning approximately 38% on a fully diluted basis.

Acquisition-related costs associated with the Merger were expensed as incurred and total $3.1 million and $60.9 million for the three and nine months ended September 30, 2020, respectively, and are included in selling, general and administrative expense in our condensed consolidated statements of income (loss). The acquisition-related transaction costs consisted primarily of investment banker fees and legal and accounting costs. 

The Merger constitutes a business combination, with the Company (formerly known as Apergy) treated as the accounting acquirer and legacy ChampionX treated as the acquired company for accounting purposes.

Legacy ChampionX provides on-site, technology-driven chemistry programs and value-enabling solutions and services to the global upstream oil and natural gas industry. 


10


Preliminary Purchase Price Allocation

The acquisition-date fair value of the consideration transferred consisted of the following:
(in thousands)
 
Equity consideration
$
1,263,931

Replacement awards attributable to pre-combination services(1)
43,964

Unfavorable supply agreement(2)
44,000

Favorable supply agreement(2)
(55,000
)
Fair value of consideration transferred
$
1,296,895


_______________________
(1) Represents the fair value of the replacement equity awards to the extent services were provided by employees of legacy ChampionX prior to closing. See Note 12—Equity And Cash Incentive Programs for additional information about the replacement equity awards.
(2) As part of the Merger, the Company entered into a Cross Supply and Product Transfer Agreement with Ecolab in which over a period of approximately three years from the merger date, certain products will be manufactured by one party for the other. The cross selling prices in which each party will transfer their products, and include a take-or-pay element, have been set forth within this agreement and are not reflective of market terms. As a result, we recognized an intangible asset recorded at fair value for the favorable terms and a liability recorded at fair value for the unfavorable terms. The intangible asset will be amortized on a straight-line basis over a three-year period into cost of goods and services and the liability will be amortized as a component of product revenue.

The purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based on their preliminary fair value estimates as of the acquisition date. The measurements of assets acquired and liabilities assumed, other than debt which was measured using Level 2 measurements, are based on inputs that are not observable in the market and thus represent Level 3 inputs. The excess of the purchase price over such fair values was recorded as goodwill. The purchase price allocation is based upon a preliminary valuation only and will be finalized upon completion of certain valuation procedures. Our estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The primary areas in which the preliminary purchase price allocation is not yet finalized relate to the fair values of certain tangible assets acquired and liabilities assumed, the valuation of intangible assets acquired, certain working capital items, deferred income taxes and residual goodwill. We will complete the purchase price allocation and valuation during the 12-month period following the Merger date.

The following table provides the preliminary allocation of the purchase price as of the acquisition date.
(in thousands)
 
Cash and cash equivalents
$
57,588

Receivables
392,409

Inventories
339,214

Prepaid expenses and other current assets
62,011

Property, plant, and equipment
690,047

Identifiable intangible assets(1)
305,000

Other non-current assets
156,002

Total identifiable assets acquired
2,002,271

Accounts payable
183,445

Other current liabilities(1)
170,433

Long-term debt (2)
537,000

Deferred tax liabilities
93,290

Other liabilities(1)
104,980

Total liabilities assumed
1,089,148

Net identifiable assets acquired
913,123

Add: Negative fair value of non-controlling interests
16,052

Goodwill
367,720

Total net assets acquired
$
1,296,895


_______________________
(1) The fair value of the consideration transferred related to the Favorable and Unfavorable supply agreements has been excluded.
(2) In connection with the Merger, we assumed a term loan from legacy ChampionX, of which approximately $26.9 million has been classified as short-term representing the mandatory amortization payments due within the next twelve months. See Note 6—Debt for further information.

11



Summary of Significant Fair Value Methods

Inventories
 
Acquired inventory is comprised of raw materials and finished goods.  The preliminary fair value of finished goods was calculated as the estimated selling price, adjusted for costs of the selling effort and a reasonable profit allowance relating to the selling effort. The preliminary fair value of raw materials and supplies was determined based on replacement cost which approximates historical carrying value.  The preliminary fair value step-up of $13.6 million of inventories measured on a First In First Out (“FIFO”) basis is amortized to cost of goods and services in the condensed consolidated financial statements as the inventory is sold, which is expected to be a period of three months from the acquisition date.  For inventories measured on a Last In First Out (“LIFO”) basis, the acquired inventory becomes the LIFO base layer inventory.

Property, Plant, and Equipment
 
The preliminary fair value of identifiable fixed assets was calculated using a combination of valuation approaches, primarily including the cost approach which adjusts estimates of replacement cost for the age, condition and utility of the associated assets, as well as the market approach to value asset types where market comparable data is available, and is summarized below:
(in thousands)
Fair Value
 
Useful Life (years)
Land and land improvements
$
125,733

 
-
Buildings and leasehold improvements
207,427

 
5 to 40
Machinery, equipment and other
337,374

 
3 to 20
Capitalized software and computer hardware
19,513

 
3 to 7
Total property, plant, and equipment acquired
$
690,047

 
 


Identifiable Intangible Assets

The preliminary fair values of trademarks, trade names, and developed technology were determined using a relief from royalty methodology which estimates cost savings generated by a company related to the ownership of an asset for which otherwise have had to pay royalties or license fees on revenues earned through the use of the asset. Customer relationships were determined using the multi-period excess earnings method which involves isolating the net earnings attributable to the asset being measured based on the present value of the incremental after-tax cash flows attributable solely to the intangible assets over its remaining useful life. Preliminary fair values are summarized below:
(in thousands)
Fair Value
 
Useful Life (years)
Trademarks and trade names
$
25,000

 
15
Developed technology
115,000

 
7
Customer relationships
165,000

 
15
Total identifiable intangible assets acquired
305,000

 

Favorable supply agreements
55,000

 
3
Total identifiable intangible assets recognized
$
360,000

 
 


The weighted average amortization period for identifiable intangible assets recognized is 10.5 years.

Leases

Lease-related assets and liabilities acquired were remeasured at the present value of the future minimum lease payments over the remaining lease term utilizing an updated incremental borrowing rate of the Company as if the acquired leases were new leases as of the acquisition date. Right-of-use assets were further adjusted for any off-market terms of the lease. The remaining lease term is based on the remaining term at the acquisition date plus any renewal or extension options that the Company is reasonably certain will be exercised. Additionally, the Company has elected short-term lease treatment for those acquired lease contracts which, at the acquisition date, have a remaining lease term of 12 months or less. For the leases acquired through the

12


Merger, the Company will retain the previous lease classification. This resulted in legacy ChampionX assets and liabilities of $100.6 million and $93.2 million, respectively, as of the acquisition date.

Goodwill

Goodwill of $367.7 million arising from the acquisition consisted largely of the expected synergies and economies of scale from combining the operations of the Company and legacy ChampionX. Goodwill recognized as a result of the acquisition is not deductible for tax purposes. We have allocated goodwill of $278.7 million and $89.0 million to our Production Chemical Technologies and Reservoir Chemical Technologies operating segments, respectively. See Note 5—Goodwill And Intangible Assets for a rollforward of our goodwill balance by operating segment.

Pro forma financial information

The results of operations for legacy ChampionX that have been included in our condensed consolidated financial statements from the June 3, 2020 acquisition date through September 30, 2020 include revenue of $644.5 million and net income of $23.1 million. The following unaudited pro forma results of operations have been prepared as though the Merger was completed on January 1, 2019. Pro forma amounts are based on the preliminary purchase price allocation of the acquisition and are not necessarily indicative of results that may be reported in the future. Non-recurring pro forma adjustments including acquisition-related costs directly attributable to the Merger are included within the reported pro forma revenue and net income (loss).
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands, except per share data)
2020
 
2019
 
2020
 
2019
Revenues
$
633,526

 
$
866,506

 
$
2,068,904

 
$
2,634,009

Net income (loss) attributable to ChampionX
4,667

 
53,251

 
(789,858
)
 
163,130


Transactions with Ecolab

Certain agreements have been entered into between the Company and Ecolab, including, among others, a Tax Matters Agreement, an Intellectual Property Matters Agreement, a Cross Supply and Product Transfer Agreement, and a Transition Services Agreement, each entered into on the Closing Date; as well as the Employee Matters Agreement entered into on December 18, 2019. Pursuant to the Transition Services Agreement, Ecolab and its subsidiaries as well as legacy ChampionX and its subsidiaries will provide each other with specified support services and other assistance for a limited time following the closing of the Merger.  Charges for services under the agreement are representative of our best estimate of market price and will be determined on an allocated cost basis, subject to an overall annual aggregate cap.  Revenue recognized under the Cross Supply and Product Transfer Agreement for the three and nine months ended September 30, 2020 was $49.5 million and $67.4 million, respectively. The Cross Supply and Product Transfer Agreement also includes a take-or-pay element which requires the Company to purchase a minimum of 13.7 million kilograms of product over a ten-year period, approximately $23.3 million. The Company has the option to terminate early beginning in the fifth year upon a two-year’s notice, subject to a termination fee which declines over the contract term.

NOTE 3—NEW ACCOUNTING STANDARDS

Recently Adopted Accounting Standards

Effective January 1, 2020, we adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This update amends the impairment model to utilize an expected credit loss methodology in place of the incurred credit loss methodology for financial instruments. We applied the provisions of this ASU to our financial instruments, mostly consisting of trade receivables, as of January 1, 2020. We utilized the modified retrospective method of adoption; therefore, prior period amounts have not been adjusted and continue to be reflected in accordance with our historical accounting policies. As of January 1, 2020, we recorded a cumulative adjustment to retained earnings of $1.6 million, net of $0.4 million of income tax benefit.

Our exposure to credit losses is primarily the result of product sales to our customers, resulting in trade receivables with payment terms generally ranging from 30 days to 90 days. We manage credit risk on trade receivables by transacting only with what management believes are financially secure customers. Accounts receivable are carried at the invoiced amounts, less an

13


allowance for doubtful accounts, and generally do not bear interest. The Company estimates the allowance for doubtful accounts for expected credit losses by analyzing accounts receivable balances by applying historical write-off and collection trend rates as well as current economic and market conditions. Specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Account balances are written off against the allowance when it is determined the receivable will not be recovered.

The following table provides a rollforward of our allowance for credit losses balance:
(in thousands)
Allowance for Credit Losses
December 31, 2019
$
8,072

Impact of adoption on January 1, 2020
2,042

Provision for expected credit losses
3,384

Accounts written off
(1,947
)
Recoveries
1,770

Foreign currency translation
(470
)
September 30, 2020
$
12,851



NOTE 4—INVENTORIES

Inventories consisted of the following:
(in thousands)
September 30, 2020
 
December 31, 2019
Raw materials
$
140,875

 
$
50,099

Work in progress
11,051

 
13,325

Finished goods
354,584

 
175,774

 
506,510

 
239,198

Inventory reserve
(17,237
)
 
(12,067
)
LIFO adjustments
(17,942
)
 
(15,789
)
Inventories, net
$
471,331

 
$
211,342



NOTE 5—GOODWILL AND INTANGIBLE ASSETS

During the first quarter of 2020, certain unprecedented events caused the rapid decline of several market indicators in the oil and gas industry. Decisions by the Organization of Petroleum Exporting Countries (“OPEC”) and other oil producing nations resulted in an oversupply of crude oil. Compounding this situation, demand for oil and gas commodities declined significantly as the world was impacted by the COVID-19 outbreak, which resulted in a sharp decline in crude oil prices. Consequently, our market capitalization was negatively impacted as a result of these market conditions and overall impact to our industry.

Management determined that these events and their related impact to future revenues and cash flows constituted a triggering event in the first quarter of 2020, requiring us to perform a recoverability test of our long-lived assets and an interim impairment assessment of goodwill as of March 31, 2020.

14






Goodwill
The carrying amount of goodwill, including changes therein, by reporting segment is below:
(in thousands)
Production Chemical Technologies
 
Production & Automation Technologies
 
Drilling Technologies
 
Reservoir Chemical Technologies
 
Total
December 31, 2019
$

 
$
809,977

 
$
101,136

 
$

 
$
911,113

Acquisition (1)
278,723

 

 

 
88,997

 
$
367,720

Impairment

 
(616,271
)
 

 

 
$
(616,271
)
Foreign currency translation
243

 
(2,473
)
 

 
(3
)
 
$
(2,233
)
September 30, 2020
$
278,966

 
$
191,233

 
$
101,136

 
$
88,994

 
$
660,329


_______________________
(1) See Note 2—Merger Transaction for additional information related to the acquisition completed during June 2020.

Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.
 
During the first quarter of 2020, we performed a quantitative analysis for each of our reporting units to determine the existence of goodwill impairment and the amount of the impairment loss. In performing the quantitative assessment, we estimated the fair value of each of our reporting units using a combination of the income and market approaches, which determined that the fair values were less than the respective carrying values for our Artificial Lift and Automation reporting units.
Our income-based valuation method determines the present value of estimated future cash flows to estimate the fair value of a reporting unit. Significant assumptions used in estimating our reporting unit fair values include: (i) annual revenue growth rates; (ii) operating margins; (iii) risk-adjusted discount rate; and (iv) terminal value determined using a long-term growth rate. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to the reporting unit. Given the unprecedented uncertainty of both short-term and long-term market conditions, we utilized a weighted-average projection for estimated future cash flows that consists of three estimated future cash flows scenarios with the following weightings: (i) low case scenario with a 40% weighting, (ii) base case scenario with a 40% weighting, and (iii) high case scenario with a 20% weighting.
Under the market approach, we estimated a fair value based on comparable companies’ market multiples of revenues and earnings before interest, taxes, depreciation and amortization and factored in a control premium. Finally, we compared our estimates of fair values to our March 31, 2020 total public market capitalization and assessed an implied control premium based on the 20-day average of our common stock. 
The reporting unit carrying values were adjusted based on the long-lived asset impairment assessment noted below. Financial and credit market volatility directly impacts our fair value measurement through the weighted average cost of capital used to determine a discount rate. During times of volatility, significant judgment must be applied to determine whether credit market changes are a short-term or long-term trend. We utilized discount rates of 14.5% and 16.5% for our Artificial Lift and Automation reporting units, respectively.
 
During the first quarter of 2020, we recorded a $616.3 million impairment charge to goodwill, consisting of $539.2 million and $77.1 million in our Artificial Lift reporting unit and our Automation reporting unit, respectively. Both reporting units are within our Production & Automation Technologies reportable segment. The goodwill impairment charge includes $560.1 million of non-taxable goodwill, which was recognized as a discrete item in determining our effective tax rate for the period. We did not identify any triggering events at any of our reporting units during the third quarter of 2020.

Long-lived Asset Impairment
Long-lived assets, which include property, plant and equipment, right-of-use assets, and identified intangible assets, comprise a significant amount of our total assets. The Company makes judgments and estimates in conjunction with the carrying value of these assets, including amounts to be capitalized, depreciation and amortization methods and estimated useful lives.
 

15





The negative market indicators described above, as well as the results of the previously mentioned fair value determinations of certain of our reporting units, were triggering events indicating that certain of our long-lived tangible and intangible assets may be impaired. We performed recoverability tests on our asset groups as of March 31, 2020, which indicated that long-lived assets associated with two of our asset groups within Production & Automation Technologies were not recoverable as the aggregate amount of estimated undiscounted cash flows of these asset groups was determined to be below their respective carrying values. We estimated the fair value of these intangible and fixed assets using an income approach that required us to make long-term forecasts of our future revenues and costs related to the assets subject to review. These forecasts utilized assumptions about demand for our products and services, future market conditions and technological developments. The forecasts are dependent upon assumptions including those regarding oil prices and the general outlook for the global oil and gas industry, among other factors. Financial and credit market volatility directly impacts our fair value measurement through our income forecast. Changes to these assumptions, including, but not limited to: variability of spot and futures prices for crude oil; sustained declines in worldwide rig counts below current analysts’ forecasts; significant deterioration of external financing for our customers; higher risk premiums or higher cost of equity; or any other significant adverse economic news could require a provision for impairment.
 
Accordingly, the estimated fair value of each of these asset groups was below their respective carrying value and as a result, we recorded a long-lived asset impairment charge of $41.0 million in the first quarter of 2020, consisting of $40.4 million to customer relationships and $0.6 million to trademarks. We did not identify impairment triggering events at any of our asset groups during the third quarter of 2020.

The components of our definite- and indefinite-lived intangible assets were as follows:
 
September 30, 2020
 
December 31, 2019
(in thousands)
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Definite-lived
intangible assets:
 
 
 
 
 
 
 
 
 
 
 
Customer relationships (1)
$
610,091

 
$
309,762

 
$
300,329

 
$
560,316

 
$
353,189

 
$
207,127

Trademarks (1)
59,860

 
26,459

 
33,401

 
35,695

 
24,830

 
10,865

Patents
38,280

 
28,547

 
9,733

 
38,436

 
26,838

 
11,598

Unpatented technologies
128,700

 
15,349

 
113,351

 
13,700

 
9,811

 
3,889

Favorable supply agreements (2)
54,728

 
5,929

 
48,799

 

 

 

Drawings and manuals
1,739

 
1,739

 

 
2,558

 
1,758

 
800

Other
5,299

 
4,723

 
576

 
5,332

 
4,504

 
828

 
898,697

 
392,508

 
506,189

 
656,037

 
420,930

 
235,107

Indefinite-lived
intangible assets:
 
 
 
 
 
 
 
 
 
 
 
Trademarks
3,600

 

 
3,600

 
3,600

 

 
3,600

Total
$
902,297

 
$
392,508

 
$
509,789

 
$
659,637

 
$
420,930

 
$
238,707

_______________________
(1) Includes impairment of customer relationship and trademark intangible assets of $40.4 million and $0.6 million, respectively, all of which relate to asset groups included within our Artificial Lift business.
(2) Favorable supply agreements were entered into as part of the Merger transaction. See Note 2—Merger Transaction for further information.

16


NOTE 6—DEBT

Long-term debt consisted of the following:
(in thousands)
September 30, 2020
 
December 31, 2019
2018 Credit Facility
$

 
$

2018 Term Loan Facility
190,000

 
265,000

2020 Term Loan Facility
530,287

 

6.375% Senior Notes due 2026
300,000

 
300,000

Finance lease obligations
9,561

 
9,375

Total
1,029,848

 
574,375

Net unamortized discounts and issuance costs
(8,688
)
 
(9,709
)
Total long-term debt
$
1,021,160

 
$
564,666

Current portion of long-term debt (1)
(31,470
)
 
(4,845
)
Long-term debt, less current portion
$
989,690

 
$
559,821


_______________________
(1) Primarily includes the mandatory amortization payments due within twelve months related to the 2020 Term Loan Facility.

2018 Credit Facility
On February 14, 2020, the Company entered into an amendment to its existing credit facility dated May 9, 2018 (as amended, the “2018 Credit Facility”), which (i) provided for the incurrence of an additional $150 million of revolving commitments under the 2018 Credit Facility, upon consummation of the Merger, (ii) permitted the consummation of the Merger and the incurrence of a senior secured term loan facility (“2020 Term Loan Facility”) in an aggregate amount up to $537 million by legacy ChampionX, and (iii) continued to provide that all obligations under the 2018 Credit Facility continue to be guaranteed by certain of the Company’s wholly owned U.S. subsidiaries, including upon the consummation of the Merger, certain legacy ChampionX wholly owned U.S. subsidiaries. The weighted average interest rate on borrowings during the period was 2.69%.
2020 Term Loan Facility

On June 3, 2020, legacy ChampionX entered into a term loan facility for $537.0 million (“2020 Term Loan Facility”). Proceeds from the 2020 Term Loan Facility were utilized to fund a cash payment of $527.4 million from legacy ChampionX to Ecolab upon the completion of the Merger. We assumed the 2020 Term Loan Facility upon completion of the Merger, which is fully and unconditionally guaranteed by the Company and certain of its wholly owned domestic subsidiaries, which also guarantee the obligations under the 2018 Credit Facility. The 2020 Term Loan Facility matures at the earlier of (i) June 3, 2027 or (ii) January 30, 2026 in the event the Company’s senior unsecured notes due May 1, 2026 remain outstanding. Amounts outstanding under the 2020 Term Loan Facility bear interest, at the option of the Company, at a rate equal to (a) LIBOR plus 5.0% for eurocurrency rate loans (to the extent LIBOR is less than 1%, the LIBOR rate will be deemed to be 1%) or (b) the highest of (i) the Federal Funds Rate plus 1/2 of 1%, (ii) the “prime rate” quoted by Bank of America, N.A., (iii) LIBOR plus 1.00% and (iv) 1.00%, plus 4.0%. The 2020 Term Loan Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. The weighted average interest rate on borrowings during the period was 6.00%.

The term loan is subject to mandatory amortization payments of $6.7 million paid quarterly, beginning on September 30, 2020. Any voluntary prepayment of the 2020 Term Loan Facility which occurs prior to June 3, 2022, is subject to a make-whole prepayment premium on the aggregate prepaid principal amount of the 2020 Term Loan Facility.

Senior Notes

ChampionX has senior notes outstanding, the payment obligations of which are fully and unconditionally guaranteed by certain wholly owned subsidiaries of ChampionX on a joint and several basis. On June 18, 2020, the wholly owned subsidiaries of legacy ChampionX that guarantee the 2018 Credit Facility and the 2020 Term Loan Facility, delivered a Supplemental Indenture to join as guarantors of the senior notes.
 

17





NOTE 7—COMMITMENTS AND CONTINGENCIES

The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred.

Guarantees and Indemnifications

We have provided indemnities in connection with sales of certain businesses and assets, including representations and warranties, covenants and related indemnities for environmental health and safety, tax and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.

In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018 (the “Separation”), we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement, we have agreed to indemnify Dover and its affiliates against any and all tax-related liabilities incurred by them relating to the Separation and/or certain related transactions to the extent caused by an acquisition of ChampionX stock or assets or by any other action or failure to act undertaken by ChampionX or its affiliates.

Pursuant to the provisions of the tax matters agreement with Dover, we recorded an indemnification liability of $3.4 million as of December 31, 2019, with respect to certain liabilities related to tax audits for the 2012-2016 tax years. We received notification in February 2020 that the tax audits and related assessments were completed, resulting in a final settlement amount of $3.0 million, which was paid in April 2020.

In connection with the Merger, we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the Tax Matters Agreement, we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the ChampionX Credit Facilities and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing.

As of September 30, 2020 and December 31, 2019, we had $51.6 million and $15.7 million, respectively, of outstanding letters of credit, surety bonds and guarantees which expire at various dates through 2025. These financial instruments are primarily maintained as security for insurance, warranty and other performance obligations. Generally, we would only be liable for the amount of these letters of credit and surety bonds in the event of default in the performance of our obligations, the probability of which we believe is remote.

Litigation and Environmental Matters

We are involved in various pending or potential lawsuits, claims and environmental actions that have arisen in the ordinary course of our business. These proceedings primarily involve claims by private parties alleging injury arising out of use of our products, patent infringement, employment matters, and commercial disputes, as well as possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain chemical substances at various sites, such as Superfund sites and either operating or owned facilities. We review the probable outcome of such proceedings, the costs and

18





expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. We are unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation and unfavorable rulings or developments could occur, and there can be no certainty that the Company may not ultimately incur changes in excess of recorded liabilities. However, we believe the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows.

Environmental Matters

The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the U.S., and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2020 environmental liability accruals related to these locations were $8.9 million.

Prior to the Separation, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma ("Norris"). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality ("ODEQ"). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. Now that we have such recommendations, we have begun discussions with ODEQ regarding our proposed long-term remediation plan. The plan is subject to ODEQ’s review, input, and approval. Because we have not yet finalized a plan for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated, however, there have been no changes to our estimated liability as of September 30, 2020.

Matters Related to Deepwater Horizon Incident Response

On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain three cases pending against the COREXIT Defendants relating to the Deepwater Horizon oil spill, all of which are expected to ultimately be dismissed pursuant to the Court’s November 28, 2012 order granting the COREXIT Defendants’ motion for summary judgment.
The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

19


NOTE 8 — ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive lossAccumulated other comprehensive loss consisted of the following:
(in thousands)
Foreign Currency Translation
 
Defined Pension and Other Post-Retirement Benefits
 
Cash Flow Hedges
 
Accumulated Other Comprehensive Loss
December 31, 2018
$
(36,146
)
 
$
(6,760
)
 
$

 
$
(42,906
)
Other comprehensive income (loss) before reclassifications, net of tax
1,090

 
(323
)
 

 
767

Reclassification adjustment for net losses included in net income, net of tax

 
422

 

 
422

Other comprehensive income, net of tax
1,090

 
99

 

 
1,189

March 31, 2019
$
(35,056
)
 
$
(6,661
)
 
$

 
$
(41,717
)
Other comprehensive income (loss) before reclassifications, net of tax
974

 

 

 
974

Reclassification adjustment for net losses included in net income, net of tax

 
68

 

 
68

Other comprehensive income (loss), net of tax
974

 
68

 

 
1,042

June 30, 2019
$
(34,082
)
 
$
(6,593
)
 
$

 
$
(40,675
)
Other comprehensive loss before reclassifications, net of tax
(2,900
)
 

 

 
(2,900
)
Reclassification adjustment for net losses included in net income, net of tax

 
68

 

 
68

Other comprehensive income (loss), net of tax
(2,900
)
 
68

 

 
(2,832
)
September 30, 2019
$
(36,982
)
 
$
(6,525
)
 
$

 
$
(43,507
)


20


(in thousands)
Foreign Currency Translation
 
Defined Pension and Other Post-Retirement Benefits
 
Cash Flow Hedges
 
Accumulated Other Comprehensive Loss
December 31, 2019
$
(35,210
)
 
$
(8,827
)
 
$

 
$
(44,037
)
Other comprehensive loss before reclassifications, net of tax
(11,052
)
 

 

 
(11,052
)
Reclassification adjustment for net losses included in net income, net of tax

 
99

 

 
99

Other comprehensive income (loss), net of tax
(11,052
)
 
99

 

 
(10,953
)
March 31, 2020
$
(46,262
)
 
$
(8,728
)
 
$

 
$
(54,990
)
Other comprehensive income before reclassifications, net of tax
5,703

 

 
653

 
6,356

Reclassification adjustment for net losses included in net income, net of tax

 
99

 

 
99

Other comprehensive income, net of tax
5,703

 
99

 
653

 
6,455

June 30, 2020
$
(40,559
)
 
$
(8,629
)
 
$
653

 
$
(48,535
)
Other comprehensive loss before reclassifications, net of tax
3,782

 

 
(862
)
 
2,920

Reclassification adjustment for net losses included in net income, net of tax

 
99

 

 
99

Other comprehensive income (loss), net of tax
3,782

 
99

 
(862
)
 
3,019

September 30, 2020
$
(36,777
)
 
$
(8,530
)
 
$
(209
)
 
$
(45,516
)



Reclassifications from accumulated other comprehensive lossReclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
Affected line items on the condensed consolidated statements of income (loss)
(in thousands)
2020
 
2019
 
2020

2019
 
Pensions and other post-retirement benefits:
Amortization of actuarial loss and other
$
132

 
$
91

 
$
396

 
$
274

 
Other (income) expense, net
Settlement loss

 

 

 
486

 
Other (income) expense, net
Total before tax
132

 
91

 
396

 
760

 
Income (loss) before income taxes
Tax benefit
(33
)
 
(23
)
 
(99
)
 
(202
)
 
Provision for (benefit from) income taxes
Net of tax
$
99

 
$
68

 
$
297

 
$
558

 
Net income (loss)



21


NOTE 9 — EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings (loss) per share calculation was as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands, except per share data)
2020
 
2019
 
2020
 
2019
Net income (loss) attributable to ChampionX
$
(7,914
)
 
$
11,394

 
$
(751,287
)
 
$
53,987

 
 
 
 
 
 
 
 
Weighted-average number of shares outstanding
199,809

 
77,460

 
131,064

 
77,416

Dilutive effect of stock-based compensation

 
113

 

 
199

Total shares and dilutive securities
199,809

 
77,573

 
131,064

 
77,615

 
 
 
 
 
 
 
 
Basic earnings (loss) per share attributable to ChampionX
$
(0.04
)
 
$
0.15

 
$
(5.73
)
 
$
0.70

Diluted earnings (loss) per share attributable to ChampionX
$
(0.04
)
 
$
0.15

 
$
(5.73
)
 
$
0.70


For all periods presented, the computation of diluted earnings (losses) per share excludes awards with an anti-dilutive impact. For the three and nine months ended September 30, 2020, we excluded all outstanding equity awards from the calculation of weighted-average shares outstanding, because their inclusion would be anti-dilutive as we were in a loss position. For the three and nine months ended September 30, 2019, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million shares that were excluded because their inclusion would be anti-dilutive.

NOTE 10—REVENUE

Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance and field services. Lease revenue is derived from rental income of leased production equipment. These lease arrangements generally allow customers to rent equipment on a daily basis with no stated end date. Management accounts for these arrangements as a daily renewal option beginning on the lease commencement date, with the lease term determined as the period in which it is reasonably certain the option will be exercised. We do not track cost of goods sold separately for all of our revenue streams.

Within our Production & Automation Technologies and Drilling Technologies segments, substantially all of our performance obligations are recognized at a point in time and are primarily related to our product revenue derived from the sale of drilling and production equipment. Revenue is recognized when control transfers to the customer upon shipment or completion of installation, testing, or certification as required under the contract. Within our Production Chemical Technologies and Reservoir Chemical Technologies segments, revenue recognized from the sale of products and equipment is recognized at the point in time when the obligations in the contract with the customer are satisfied, which generally occurs with the transfer of the product or delivery of the equipment.

In certain markets, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. As of September 30, 2020, accrued distributor fees were $36.4 million and nil at December 31, 2019.



22


Disaggregation of Revenue

Revenue disaggregated by revenue type was as follows:
 
Three Months Ended September 30,
 
Nine Months Ended
September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Production Chemical Technologies:
 
 
 
 
 
 
 
Product revenue
$
361,167

 
$

 
$
480,634

 
$

Service revenue
46,933

 

 
63,165

 

Lease and other revenue
2,051

 

 
2,354

 

Total Production Chemical Technologies revenue
$
410,151

 
$

 
$
546,153

 
$

Production & Automation Technologies:
 
 
 
 
 
 
 
Product revenue
$
96,605

 
$
185,051

 
$
347,477

 
$
572,797

Service revenue
26,331

 
23,918

 
70,720

 
71,781

Lease and other revenue
13,985

 
12,993

 
38,944

 
36,161

Total Production & Automation Technologies revenue
$
136,921

 
$
221,962

 
$
457,141

 
$
680,739

Drilling Technologies:
 
 
 
 
 
 
 
Product revenue
$
15,706

 
$
54,816

 
$
92,576

 
$
202,692

Service revenue
9

 
61

 
42

 
72

Total Drilling Technologies revenue
$
15,715

 
$
54,877

 
$
92,618

 
$
202,764

Reservoir Chemical Technologies:
 
 
 
 
 
 
 
Product revenue
$
21,234

 
$

 
$
30,473

 
$

Service revenue
30

 

 
97

 

Total Reservoir Chemical Technologies revenue
$
21,264

 
$

 
$
30,570

 
$

Corporate and other: (1)
 
 
 
 
 
 
 
Product revenue
$
46,113

 
$

 
$
62,980

 
$

Service revenue
3,362

 

 
4,412

 

Total Corporate and other revenue
$
49,475

 
$

 
$
67,392

 
$

Total Revenue:
 
 
 
 
 
 
 
Product revenue
$
540,825

 
$
239,867

 
$
1,014,140

 
$
775,489

Service revenue
76,665

 
23,979

 
138,436

 
71,853

Lease and other revenue
16,036

 
12,993

 
41,298

 
36,161

Total revenue
$
633,526

 
$
276,839

 
$
1,193,874

 
$
883,503


_______________________
(1) Revenue generated from the Cross Supply and Product Transfer Agreement with Ecolab is recorded to Corporate. See Note 2—Merger Transaction for additional information on this arrangement.


23


Revenue disaggregated by geography was as follows:
 
Three Months Ended September 30, 2020
(in thousands)
Production Chemical Technologies
 
Production & Automation Technologies
 
Drilling Technologies
 
Reservoir Chemical Technologies
 
Corporate
 
Total
United States
$
136,689

 
$
100,875

 
$
11,308

 
$
10,901

 
$
33,125

 
$
292,898

Canada
53,681

 
6,018

 
942

 
686

 
136

 
61,463

Middle East
66,352

 
10,899

 
182

 
4,696

 
6,048

 
88,177

Europe
45,720

 
1,823

 
1,948

 
715

 
5,822

 
56,028

Australia
5,944

 
11,266

 
32

 
82

 

 
17,324

Latin America
80,761

 
4,319

 

 
1,696

 
1,278

 
88,054

Asia-Pacific
11,931

 
1,382

 
818

 
882

 
3,066

 
18,079

Other
9,073

 
339

 
485

 
1,606

 

 
11,503

Total revenue
$
410,151

 
$
136,921

 
$
15,715

 
$
21,264

 
$
49,475

 
$
633,526



 
Nine Months Ended September 30, 2020
(in thousands)
Production Chemical Technologies
 
Production & Automation Technologies
 
Drilling Technologies
 
Reservoir Chemical Technologies
 
Corporate
 
Total
United States
$
178,442

 
$
338,457

 
$
66,142

 
$
15,177

 
$
45,057

 
$
643,275

Canada
69,641

 
23,140

 
6,213

 
817

 
198

 
100,009

Middle East
94,500

 
33,065

 
722

 
7,583

 
8,485

 
144,355

Europe
62,864

 
9,481

 
9,543

 
987

 
7,048

 
89,923

Australia
7,827

 
32,801

 
101

 
93

 

 
40,822

Latin America
105,795

 
15,034

 
22

 
2,183

 
1,768

 
124,802

Asia-Pacific
15,623

 
4,653

 
8,495

 
1,155

 
4,836

 
34,762

Other
11,461

 
510

 
1,380

 
2,575

 

 
15,926

Total revenue
$
546,153

 
$
457,141

 
$
92,618

 
$
30,570

 
$
67,392

 
$
1,193,874


 
Three Months Ended September 30, 2019
(in thousands)
Production Chemical Technologies
 
Production & Automation Technologies
 
Drilling Technologies
 
Reservoir Chemical Technologies
 
Corporate
 
Total
United States
$

 
$
169,658

 
$
39,705

 
$

 
$

 
$
209,363

Canada

 
14,012

 
5,212

 

 

 
19,224

Middle East

 
16,030

 
286

 

 

 
16,316

Europe

 
4,530

 
5,939

 

 

 
10,469

Australia

 
7,919

 
83

 

 

 
8,002

Latin America

 
6,816

 
19

 

 

 
6,835

Asia-Pacific

 
2,239

 
3,335

 

 

 
5,574

Other

 
758

 
298

 

 

 
1,056

Total revenue
$

 
$
221,962

 
$
54,877

 
$

 
$

 
$
276,839



24


 
Nine Months Ended September 30, 2019
(in thousands)
Production Chemical Technologies
 
Production & Automation Technologies
 
Drilling Technologies
 
Reservoir Chemical Technologies
 
Corporate
 
Total
United States
$

 
$
527,893

 
$
149,880

 
$

 
$

 
$
677,773

Canada

 
39,712

 
14,296

 

 

 
54,008

Middle East

 
43,440

 
920

 

 

 
44,360

Europe

 
14,384

 
26,134

 

 

 
40,518

Australia

 
21,927

 
83

 

 

 
22,010

Latin America

 
23,917

 
19

 

 

 
23,936

Asia-Pacific

 
8,307

 
10,678

 

 

 
18,985

Other

 
1,159

 
754

 

 

 
1,913

Total revenue
$

 
$
680,739

 
$
202,764

 
$

 
$

 
$
883,503



Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract balances

Contract assets and contract liabilities from contracts with customers were as follows:
(in thousands)
September 30, 2020
 
December 31, 2019
Contract assets
$

 
$
285

Contract liabilities - current
16,883

 
6,148



NOTE 11—RESTRUCTURING AND OTHER RELATED CHARGES

Restructuring and other related charges as classified in our condensed consolidated statements of income (loss) were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended
September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Segment restructuring charges (1):
 
 
 
 
 
 
 
Production Chemical Technologies
$
2,305

 
$

 
$
2,305

 
$

Production & Automation Technologies
914

 
1,246

 
9,919

 
2,317

Drilling Technologies

 
526

 
5,521

 
526

Reservoir Chemical Technologies
207

 

 
207

 

Corporate

 

 
368

 

Total
$
3,426

 
$
1,772

 
$
18,320

 
$
2,843

 
 
 
Statements of Income (Loss) classification:
 
 
 
 
 
 
 
Cost of goods and services
$
2,228

 
$
1,344

 
$
12,974

 
$
1,743

Selling, general and administrative expense
1,198

 
428

 
5,346

 
1,100

Total (1)
$
3,426

 
$
1,772

 
$
18,320

 
$
2,843


_______________________
(1) Total restructuring expenses include asset write-downs, which are not included in the restructuring accrual below.

Restructuring and other related charges during the three and nine months ended September 30, 2020 included the following activities, which the Company expects will be completed by early 2021:

Production Chemical Technologies. Production Chemical Technologies incurred restructuring charges of $2.3 million during the three and nine months ended September 30, 2020, primarily due to costs associated with employee severance and related benefits as a result of workforce reductions to better align the cost base with the significantly lower demand environment.


25


Production & Automation Technologies. Production & Automation Technologies incurred restructuring charges of $0.9 million and $9.9 million during the three and nine months ended September 30, 2020, respectively, related to various programs, primarily focused on facility closures and consolidations, exit of certain nonstrategic product lines, and workforce reductions.

Drilling Technologies. Drilling Technologies incurred restructuring charges of $5.5 million during the nine months ended September 30, 2020, primarily due to costs associated with employee severance and related benefits as a result of workforce reductions and facility closures to better align the cost base with the significantly lower demand environment.

Reservoir Chemical Technologies. Reservoir Chemical Technologies incurred restructuring charges of $0.2 million during the three and nine months ended September 30, 2020, primarily due to costs associated with employee severance and related benefits as a result of workforce reductions to better align the cost base with the significantly lower demand environment.

The following table details our restructuring accrual activities during the nine months ended September 30, 2020:
(in thousands)
Restructuring Accrual Balance
December 31, 2019
$
130

Restructuring charges and asset write downs
10,993

Payments
(12,078
)
Liabilities assumed in the Merger
4,843

Other, including foreign currency translation
(39
)
September 30, 2020
$
3,849



Our liability balance for restructuring and other related charges at September 30, 2020, reflects employee severance and related benefits initiated during the period as well as liabilities assumed in the Merger. Additional programs may be initiated during 2020 with related restructuring charges.

NOTE 12—EQUITY AND CASH INCENTIVE PROGRAMS

Stock-based compensation expense is reported within “Selling, general and administrative expense” in the condensed consolidated statements of income (loss). Stock-based compensation expense relating to all stock-based incentive plans was as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Stock-based compensation expense
$
5,856

 
$
2,524

 
$
13,718

 
$
7,545

Tax benefit
(1,342
)
 
(615
)
 
(3,144
)
 
(1,841
)
Stock-based compensation expense, net of tax
$
4,514

 
$
1,909

 
$
10,574

 
$
5,704



A summary of activity relating to our share-based awards for the nine months ended September 30, 2020, was as follows:
(in shares)
Stock-Settled Appreciation Rights
 
Performance Share Awards
 
Restricted Stock Units
 
Non-Qualified Stock Options
Outstanding at January 1, 2020
422,361

 
174,726

 
440,048

 

Granted

 
121,261

 
583,814

 

Replacement awards (1)

 

 
2,357,733

 
7,324,853

Forfeited
(7,030
)
 
(5,011
)
 
(24,834
)
 
(9,693
)
Exercised / vested

 
(6,891
)
 
(164,314
)
 
(946
)
Outstanding at September 30, 2020
415,331

 
284,085

 
3,192,447

 
7,314,214

_______________________
(1) In connection with the Merger, the Company entered into the Employee Matters Agreement dated December 18, 2019, which provided the terms in which certain Ecolab share-based awards held by legacy ChampionX employees were replaced with share-based awards of the Company on the merger date. The fair value of the replacement awards has been allocated between each employee’s pre-combination and post-combination services. Amounts allocated to pre-combination services have been included as consideration transferred as part of the Merger. See Note 2—Merger Transaction for a summary of consideration

26


transferred. Compensation costs of $15.8 million allocated to post-combination services will be recorded as stock-based compensation expense over each employees’ remaining service period.

NOTE 13—FAIR VALUE MEASUREMENTS

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:
Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2- Inputs include observable inputs other than quoted prices in active markets.
Level 3- Inputs are unobservable inputs for which there is little or no market data available.
The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:
 
September 30, 2020
 
Carrying Amount
 
Fair Value Measurements
(in thousands)
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Foreign currency forward contracts
$
1,392

 
$

 
$
1,392

 
$

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Foreign currency forward contracts
$
4,647

 
$

 
$
4,647

 
$



The carrying value of foreign currency forward contracts is at fair value, which is determined based on foreign currency exchange rates as of the balance sheet date and is classified within Level 2. For purposes of fair value disclosure above, derivative values are presented gross. See Note 14—Derivatives And Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.

The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature.

The fair value of our senior notes is based on Level 1 quoted market prices. The fair value of our term loan facilities are based on Level 2 quoted market prices for the same or similar debt instruments. The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:
 
September 30, 2020
 
December 31, 2019
(in thousands)
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
2018 Term Loan Facility
$
190,000

 
$
185,963

 
$
265,000

 
$
266,161

2020 Term Loan Facility
$
530,287

 
$
527,636

 
$

 
$

6.375% Senior Notes due 2026
$
300,000

 
$
288,300

 
$
300,000

 
$
316,710



We consider the inputs for our long-lived asset and goodwill impairment calculations to be Level 3 inputs in the fair value hierarchy. See Note 5—Goodwill And Intangible Assets for further information.


27


NOTE 14—DERIVATIVES AND HEDGING TRANSACTIONS

The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluate hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.

The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.

Derivative Positions Summary

Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet. We did not have outstanding derivatives at December 31, 2019:
 
September 30, 2020
(in thousands)
Derivative Assets
 
Derivative Liabilities
Prepaid expenses and other current assets
$
1,392

 
$

Accrued expenses and other current liabilities

 
4,647

 
$
1,392

 
$
4,647


The following table summarizes the notional values of the Company’s outstanding derivatives:
(in thousands)
September 30, 2020
 
December 31, 2019
Notional value of foreign currency forward contracts
$
457,239

 
$



Cash Flow Hedges

The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statement of income as the underlying exposure being hedged.

Derivatives Not Designated as Hedging Instruments

The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the

28


value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.
Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:
 
Three Months Ended September 30,
 
Nine Months Ended
September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Loss reclassified from AOCI to income on cash flow hedges:
 
 
 
 
 
 
 
Cost of goods and services
$
19

 
$

 
$
34

 
$

Loss on derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
Other (income) expense, net
772

 

 
1,483

 

Total loss of derivative instruments
$
791

 
$

 
$
1,517

 
$



NOTE 15 — SEGMENT INFORMATION

Upon completion of the Merger, the Company re-evaluated its reporting segments. Our determination of reporting segments was made on the basis of our strategic priorities within each segment and corresponds to the manner in which our chief operating decision maker reviews and evaluates operating performance to make decisions about resources to be allocated to the segment. In addition to our strategic priorities, segment reporting is also based on differences in the products and services we provide. As a result, we added two new reportable segments - Production Chemical Technologies and Reservoir Chemical Technologies. The legacy Apergy reportable segments remain unchanged.

Our reporting segments are:

Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.

Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline and Windrock.

Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand.

Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs in the oil and natural gas industry.

Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.



29



Segment revenue and segment operating profit were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Segment revenue:
 
 
 
 
 
 
 
Production Chemical Technologies
$
410,151

 
$

 
$
546,153

 
$

Production & Automation Technologies
136,921

 
221,962

 
457,141

 
680,739

Drilling Technologies
15,715

 
54,877

 
92,618

 
202,764

Reservoir Chemical Technologies
21,264

 

 
30,570

 

Corporate and other (1)
49,475

 

 
67,392

 

Total revenue
$
633,526

 
$
276,839

 
$
1,193,874

 
$
883,503

 
 
 
 
 
 
 
 
Segment operating profit (loss):
 

 
 

 
 
 
 
Production Chemical Technologies
$
35,172

 
$

 
$
45,094

 
$

Production & Automation Technologies
(7,454
)
 
18,917

 
(693,213
)
 
51,849

Drilling Technologies
(5,127
)
 
13,797

 
2,421

 
64,853

Reservoir Chemical Technologies
(3,819
)
 

 
(6,630
)
 

Total segment operating profit (loss)
18,772

 
32,714

 
(652,328
)
 
116,702

Corporate and other (1)
14,131

 
8,111

 
93,192

 
16,668

Interest expense, net
15,935

 
9,590

 
36,236

 
30,226

Income (loss) before income taxes
$
(11,294
)
 
$
15,013

 
$
(781,756
)
 
$
69,808

_______________________
(1)
Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply Agreement with Ecolab are included within Corporate and other. See Note 2—Merger Transaction for further information.

Legacy ChampionX has an integrated supply chain function that serves the Production Chemical Technologies and Reservoir Chemical Technologies reportable segments. As such, asset information for these reportable segments has not been provided and is not available, since the Company does not produce or utilize such information.

NOTE 16—CASH FLOW INFORMATION

Supplemental cash flow information is as follows:
 
 
Nine Months Ended September 30,
(in thousands)
 
2020
 
2019
Non-cash information:
 
 
 
 
Finance lease additions
 
$
4,071

 
$
3,990



Lease program

Our ESP leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our lease program. During the nine months ended September 30, 2020 and September 30, 2019, we transferred $26.5 million and $61.2 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows.  All other capitalizable expenditures for assets that are placed into our lease asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows. During the nine months ended September 30, 2020 and 2019, such expenditures were estimated to be $12.9 million and $13.9 million, respectively.

30


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s discussion and analysis is our analysis of our financial performance, financial condition and significant trends that may affect our future performance. It should be read in conjunction with the condensed consolidated financial statements, and notes thereto, included elsewhere in this report. It contains forward-looking statements including, without limitation, statements relating to ChampionX’s plans, strategies, objectives, expectations and intentions that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.
Readers are cautioned that such forward-looking statements should be read in conjunction with the disclosures under the heading “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS.”


EXECUTIVE OVERVIEW AND BUSINESS OUTLOOK

ChampionX is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely and efficiently around the world. ChampionX’s products provide efficient functioning throughout the lifecycle of a well with a focus on the production phase of wells. Our Production Chemical Technologies segment provides chemistry solutions to maximize production from flowing oil and gas wells, and our Reservoir Chemical Technologies segment provides chemistry solutions used in drilling and completion activities. ChampionX’s Production & Automation Technologies offerings consist of artificial lift equipment and solutions, including rod pumping systems, electric submersible pump systems, progressive cavity pumps and drive systems and plunger lifts, as well as a full automation and digital offering consisting of equipment and software for Industrial Internet of Things (“IIoT”) solutions for downhole monitoring, wellsite productivity enhancement, and asset integrity management. ChampionX’s Drilling Technologies offering provides market leading polycrystalline diamond cutters and bearings that result in cost effective and efficient drilling.

On June 3, 2020, the Company and Ecolab completed a Reverse Morris Trust transaction in which Ecolab transferred their upstream energy business to legacy ChampionX and, thereafter, distributed all of the shares of legacy ChampionX common stock to certain Ecolab stockholders. Immediately following the Distribution, a wholly owned subsidiary of the Company merged with and into legacy ChampionX, with legacy ChampionX continuing as the surviving company in the Merger and as a wholly owned subsidiary of the Company. The Merger constitutes a business combination, with the Company (formerly known as Apergy) treated as the accounting acquirer and legacy ChampionX treated as the acquired company for accounting purposes. In association with the completion of the Merger, the Company has changed its name from Apergy Corporation to ChampionX Corporation, and common shares began trading on the New York Stock Exchange under the symbol “CHX”. See Note 2—Merger to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

In connection with the Merger, we reorganized our reportable segments. As a result, we have identified two new reportable segments, Production Chemical Technologies and Reservoir Chemical Technologies, which include the results of operations of legacy ChampionX. The legacy Apergy reportable segments remain unchanged. The results of operations of legacy ChampionX have been reflected in our accompanying condensed consolidated financial statements from the closing date of the Merger through September 30, 2020. Results for the periods prior to June 3, 2020 reflect the financial and operating results of legacy Apergy and do not include the financial and operating results of legacy ChampionX. As such, our historical results of operations are not comparable from period to period and may not be comparable to our financial results of operations in future periods.

Basis of Presentation

We revised our previously issued financial statements for the three and nine months ended September 30, 2019, for the correction of immaterial errors. In addition, we made certain reclassifications to conform to the presentation of the current period financial statements. Refer to Note 1—Basis of Presentation to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. For more information on our segments, see Note 15 — Segment Information to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

31



Business Environment

We focus on economic- and industry-specific drivers and key risk factors affecting our business segments as we formulate our strategic plans and make decisions related to allocating capital and human resources. Our business segments provide a broad range of technologies and products for the oil and gas drilling and production industry and, as a result, are substantially dependent upon activity levels in the oil and gas industry. Demand for our products, technologies and services is impacted by overall global demand for oil and gas, ongoing depletion rates of existing wells which produce oil and gas, and our customers’ willingness to invest in the development and production of oil and gas resources. Our customers determine their operating and capital budgets based on current and future crude oil and natural gas prices, U.S. and worldwide rig count and U.S. well completions, among other factors. Crude oil and natural gas prices are impacted by supply and demand, which are influenced by geopolitical, macroeconomic and local events and have historically been subject to substantial volatility and cyclicality. Future higher crude oil and natural gas prices typically translate into higher exploration and production budgets. Rig count, footage drilled and exploration and production investment by oil and gas operators have often been used as leading indicators for the level of drilling and development activity in the oil and gas sector.

Market Conditions and Outlook

During the first half of 2020, certain unprecedented events caused the rapid decline of oil prices. Decisions by the Organization of Petroleum Exporting Countries (“OPEC”) and other oil producing nations resulted in an oversupply of crude oil. Compounding this situation, demand for oil and gas commodities declined significantly as the world was impacted by the novel coronavirus (“COVID-19”) outbreak, which resulted in a sharp decline in crude oil prices. In response to the significant reduction in oil prices, customer spending associated with drilling and exploration and production (E&P) activity deteriorated at a rapid pace due to reduced drilling activities, lower budgeted capital and operating expenditures and cost cutting initiatives.

Although oil prices rebounded moderately, we are still below average oil prices experienced during 2019. We expect market conditions to remain challenging throughout the remainder of 2020 and into 2021 as we believe it will take time for global oil demand to recover from the COVID-19 pandemic and for oil supplies to return to normal levels. Outside of the incremental revenues associated with the Merger, we experienced a sequential increase in revenue in North America, primarily within our Production and Automation Technologies segment. This increase was driven by higher volumes across our artificial lift portfolio as customer spending began to recover from the compressed levels experienced during the second quarter. Internationally, markets have been more resilient, particularly in Australia and the Middle East, as the need for artificial lift in those regions is increasing and the international sales cycle is longer than the North American cycle.

Response to the COVID-19 Pandemic

In response to impacts of the COVID-19 pandemic, we implemented a set of immediate actions to reduce operating costs and capital spending. These actions are expected to generate annualized operating cost savings of $135 million during fiscal year 2020 and include:

reduction in total ChampionX headcount;
company-wide salary reductions, including steeper reductions for executive management and the highest reduction for our chief executive officer; and
facility rationalization and elimination of non-essential expenses.

Additionally, we have significantly reduced capital expenditures and expect a full year reduction of approximately $50 million, including ESP leased assets within our Production & Automation Technologies segment. On our recently acquired Chemical Technologies business, we have reduced capital spend by 50% against prior year levels. We are continuing to monitor market developments and will take additional restructuring actions should further declines in oilfield service activities occur.

Ensuring the health and safety of our employees is paramount. As our businesses are classified as critical infrastructure, our manufacturing and field locations continue to operate and support the vital oil and gas infrastructure around the world. In order to protect our employees during this period, we mobilized our crisis management team and have adopted a comprehensive response plan, which includes:

taking precautions consistent with local, state, and national government health authority guidelines, including the Centers for Disease Control and Prevention and the World Health Organization;

32


meetings between the crisis management team and executive management to ensure real-time understanding of developments as they occur such that our communications and responses are appropriate and timely;
equipping our employees with additional personal protective equipment;
introducing new employee screening procedures in our operations; and
enacting social distancing procedures, including staggering shifts, implementing rotating work schedules, and modifying workspaces and break areas.

CRITICAL ACCOUNTING ESTIMATES

Refer to our “Critical Accounting Estimates” included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2019, for a discussion of our critical accounting estimates, together with the following additional critical accounting estimate:

Determination of Fair Value in Business Combinations

Accounting for the acquisition of a business requires the allocation of the purchase price to the various assets acquired and liabilities assumed at their respective fair values. The determination of fair value requires the use of significant estimates and assumptions, and in making these determinations, management uses all available information. If necessary, we have up to one year after the acquisition closing date to finalize these fair value determinations under the applicable GAAP. For tangible and identifiable intangible assets acquired in a business combination, the determination of fair value utilizes several valuation methodologies including discounted cash flows which has assumptions with respect to the timing and amount of future revenue and expenses associated with an asset. The assumptions made in performing these valuations include, but are not limited to, discount rates, future revenues and operating costs, projections of capital costs, and other assumptions believed to be consistent with those used by principal market participants. Due to the specialized nature of these calculations, we engage third-party specialists to assist management in evaluating our assumptions as well as appropriately measuring the fair value of assets acquired and liabilities assumed.


33


CONSOLIDATED RESULTS OF OPERATIONS
THREE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019

 
Three Months Ended
 
 
 
 
 
September 30,
 
Change
(dollars in thousands)
2020
 
2019
 
$
 
%
Revenue
$
633,526

 
$
276,839

 
356,687

 
128.8
%
Cost of goods and services
505,066

 
184,140

 
320,926

 
*

Gross profit
128,460

 
92,699

 
35,761

 
38.6
%
Selling, general and administrative expense
122,156

 
68,405

 
53,751

 
78.6
%
Interest expense, net
15,935

 
9,590

 
6,345

 
66.2
%
Other (income) expense, net
1,663

 
(309
)
 
1,972

 
*

Income (loss) before income taxes
(11,294
)
 
15,013

 
(26,307
)
 
*

Provision for (benefit from) income taxes
(3,962
)
 
3,425

 
(7,387
)
 
*

Net income (loss)
(7,332
)
 
11,588

 
(18,920
)
 
*

Net income attributable to noncontrolling interest
582

 
194

 
388

 
*

Net income (loss) attributable to ChampionX
$
(7,914
)
 
$
11,394

 
(19,308
)
 
*

 
 
 
 
 
 
 
 
Gross profit margin
20.3
%
 
33.5
%
 
 
 
(1320) bps.

SG&A expense, percent of revenue
19.3
%
 
24.7
%
 
 
 
(540) bps.

Effective tax rate
35.1
%
 
22.8
%
 
 
 
1230 bps.

_______________________
*
Not meaningful

Revenue. Revenue increased $356.7 million, or 128.8%, in the third quarter of 2020 compared to prior year as a result of $481.2 million of incremental revenues from our recently acquired Chemicals Technologies business. Offsetting these incremental revenues was a $85.0 million decrease in revenue in our Production & Automation Technologies segment driven by a decline in drilling and completion activities and related reduced customer spending in North America and internationally, which affected our artificial lift, digital products, and other production equipment offerings. Additionally, there was a $39.2 million decrease in revenue in our Drilling Technologies segment primarily due to a steep decline in U.S. land-based rig count and drilling activity in the first quarter of 2020.

Gross profit. Gross profit increased $35.8 million, or 38.6%, in third quarter of 2020 compared to the prior year mainly due to $100.1 million of gross profit generated by our recently acquired Chemicals Technologies business, offset by lower sales volume at both Production & Automation Technologies and Drilling Technologies segments, and an increase in depreciation expense of $23.2 million primarily due to a change in salvage value estimate for certain of our leased assets, and depreciation expense incurred on assets acquired related to the Merger.

Selling, general and administrative expense. Selling, general and administrative expense increased $53.8 million, or 78.6%, in the third quarter of 2020 compared to the prior year primarily due to $68.0 million of selling, general and administrative expense generated by our recently acquired Chemicals Technologies business subsequent to the acquisition date. The increase also includes acquisition and integration costs of $8.4 million associated with the merger with legacy ChampionX. The increase in selling, general and administrative expense was partially offset by cost savings resulting from restructuring actions taken in the latter half of 2019 and the second quarter of 2020.

Interest expense, net. Interest expense, net increased $6.3 million in the third quarter of 2020 compared to prior year primarily due to incremental interest expense related to the term loan assumed as part of the Merger.

Provision for (benefit from) income taxes. Our provision for (benefit from) income taxes reflected effective tax rates of 35.1% and 22.8%, in the third quarter of 2020 and 2019, respectively. The effective tax rate was impacted by the effects of valuation allowances in loss jurisdictions and foreign branch earnings.



34


CONSOLIDATED RESULTS OF OPERATIONS
NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019

 
Nine Months Ended
 
 
 
 
 
September 30,
 
Change
(dollars in thousands)
2020
 
2019
 
$
 
%
Revenue
$
1,193,874

 
$
883,503

 
$
310,371

 
35.1
 %
Cost of goods and services
950,845

 
579,033

 
371,812

 
64.2
 %
Gross profit
243,029

 
304,470

 
(61,441
)
 
(20.2
)%
Selling, general and administrative expense
330,956

 
199,221

 
131,735

 
66.1
 %
Goodwill impairment
616,271

 

 
616,271

 
*

Long-lived asset impairment
40,980

 
1,746

 
39,234

 
*

Interest expense, net
36,236

 
30,226

 
6,010

 
19.9
 %
Other (income) expense, net
342

 
3,469

 
(3,127
)
 
(90.1
)%
Income (loss) before income taxes
(781,756
)
 
69,808

 
(851,564
)
 
*

Provision for (benefit from) income taxes
(31,922
)
 
15,274

 
(47,196
)
 
*

Net income (loss)
(749,834
)
 
54,534

 
(804,368
)
 
*

Net income attributable to noncontrolling interest
1,453

 
547

 
906

 
*

Net income (loss) attributable to ChampionX
$
(751,287
)
 
$
53,987

 
(805,274
)
 
*

 
 
 
 
 
 
 
 
Gross profit margin
20.4
%
 
34.5
%
 
 
 
(1410) bps.

SG&A expense, percent of revenue
27.7
%
 
22.5
%
 
 
 
520 bps.

Effective tax rate
4.1
%
 
21.9
%
 
 
 
(1780) bps.

_______________________
* Not meaningful

Revenue. Revenue for the first nine months of 2020 increased $310.4 million, or 35.1%, year-over-year driven by $644.5 million of incremental revenues associated with our recently acquired Chemicals Technologies business. The increase in revenue was offset by a decrease in Drilling Technologies revenue of $110.1 million year-over-year due to lower volumes and pricing pressure. Additionally, Production & Automation Technologies revenue decreased $223.6 million year-over-year, driven by lower volumes in North America and internationally, and the disposition of our pressure vessel manufacturing business in the second quarter of 2019.

Gross profit. Gross profit for the first nine months of 2020 decreased $61.4 million, or 20.2%, year-over year, reflecting lower sales volumes in our Production & Automation Technologies and Drilling Technologies segments. The decrease is also attributable to an increase in depreciation expense of $45.8 million, primarily due to a change in salvage value estimate for certain of our leased assets and incremental depreciation expense incurred on assets acquired related to the Merger. The decrease in gross profit in Drilling Technologies and Production & Automation Technologies is partially offset with gross profit of $127.0 million generated subsequent to the Merger date by our recently acquired Chemicals Technologies business.

Selling, general and administrative expense. Selling, general and administrative expense for the first nine months of 2020 increased $131.7 million, or 66.1%, year-over-year, primarily due to $92.7 million of selling, general and administrative expense generated subsequent to the acquisition date by our recently acquired Chemicals Technologies business as well as acquisition and integration costs of $78.0 million related to the Merger. The increase also includes an increase of $4.2 million for restructuring charges, and $5.3 million for professional fees incurred related to material weakness remediation. The increase in selling, general and administrative expense was partially offset by cost savings from restructuring actions taken in the second half of 2019 and the second quarter of 2020.

Interest expense, net. Interest expense, net in the first nine months of 2020 increased $6.0 million year-over-year due to a draw on our revolving credit facility during the second quarter, as well as incremental interest expense related to the term loan assumed as part of the Merger, partially offset by the repayment of $75 million of the Company’s term loan during the quarter.


35


Provision for (benefit from) income taxes. The effective tax rates for the first nine months of 2020 and 2019 were 4.1% and 21.9% respectively. The tax benefit recognized during 2020 reflects the loss before income taxes, largely due to goodwill and intangible asset impairment charges recorded during the first quarter. The effective tax rate was primarily impacted by the tax effects of impairment of non-taxable goodwill of $560.1 million, recognized as a discrete item. Other items impacting the rate include the effects of valuation allowances in loss jurisdictions and foreign branch earnings.

SEGMENT RESULTS OF OPERATIONS
THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019

Production Chemical Technologies
(dollars in thousands)
 
Three Months Ended September 30, 2020
Nine Months Ended September 30, 2020 (1)
Revenue
 
$
410,151

$
546,153

Operating profit
 
35,172

45,094

Operating profit margin
 
8.6
%
8.3
%
 
 
 
 
Depreciation and amortization
 
$
26,407

$
33,364

_______________________
(1) The results of operations of the Production Chemical Technologies segment have been reflected in the table above from the closing date of the Merger through September 30, 2020.

Revenue. Production Chemical Technologies revenue is primarily generated from providing E&P and other customers in the oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues. Revenue was $410.2 million for the period. Deteriorating market conditions during the second and third quarters of 2020 have significantly impacted customer demand; however, as Production Chemical Technologies mostly supports existing production, sales are somewhat less sensitive to changes in customers’ capital and operating expenditure budgets related to the exploration for and development of new oil and natural gas reserves, which are more directly affected by trends in oil and natural gas prices.

Operating profit. Production Chemical Technologies generated operating profit of $35.2 million during the three months ended September 30, 2020, which includes depreciation and amortization expense of $26.4 million and an increase to cost of goods sold related to the step-up of inventory as part of the purchase price allocation of $7.6 million.

 Production & Automation Technologies
 
 
Three Months Ended September 30,
 
Change
(dollars in thousands)
 
2020
 
2019
 
$
 
%
Revenue
 
$
136,921

 
$
221,962

 
(85,041
)
 
(38.3
)%
Operating profit (loss)
 
(7,454
)
 
18,917

 
(26,371
)
 
(139.4
)%
Operating profit (loss) margin
 
(5.4
)%
 
8.5
%
 
 
 
(1390) bps.

 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
30,221

 
$
27,196

 
3,025

 
11.1
 %
Restructuring and other related charges
 
914

 
2,194

 
(1,280
)
 
(58.3
)%
Environmental costs
 

 
1,988

 
(1,988
)
 
(100.0
)%
Acquisition transaction costs
 
250

 
167

 
83

 
49.7
 %
______________________
*
Not meaningful

Revenue. Production & Automation Technologies revenue decreased $85.0 million, or 38.3%, as compared to the prior year, primarily due to a decline in customer spending as a result of deteriorating market conditions during the second and third quarters of 2020. The decline in customer spending led to lower volumes and associated lower revenue in our artificial lift, digital products and other production equipment offerings in North America and international markets.


36


Operating profit. Production & Automation Technologies operating profit decreased $26.4 million in the third quarter of 2020 compared to the prior year primarily due to lower sales volume as noted above. The decrease in costs of goods and services of approximately $42.9 million as well as a $14.5 million reduction in selling, general and administrative costs partially offset the decline in revenue. The decline in costs is predominantly volume driven, further supplemented by various cost reduction initiatives initiated during the latter part of 2019 and first half of 2020 in response to the economic downturn. These cost initiatives were implemented to better align the segment’s cost base with the significantly lower demand environment.

 
 
Nine Months Ended September 30,
 
Change
(dollars in thousands)
 
2020
 
2019
 
$
 
%
Revenue
 
$
457,141

 
$
680,739

 
(223,598
)
 
(32.8
)%
Operating profit (loss)
 
(693,213
)
 
51,849

 
(745,062
)
 
*

Operating profit (loss) margin
 
(151.6
)%
 
7.6
%
 
 
 
(15920) bps.

 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
99,327

 
$
82,177

 
17,150

 
20.9
 %
Goodwill impairment
 
616,271

 

 
616,271

 
*

Long Lived Asset Impairment
 
40,980

 
1,746

 
39,234

 
*

Restructuring and other related charges **
 
9,919

 
6,225

 
3,694

 
59.3
 %
Environmental costs
 

 
1,988

 
(1,988
)
 
(100.0
)%
Acquisition transaction costs
 
910

 
167

 
743

 
*

_______________________
*
Not meaningful
** Includes a $2.5 million loss on disposal during the nine months ended September 30, 2019, related to our pressure vessel manufacturing business.

Revenue. Production & Automation Technologies revenue for the nine months of 2020 decreased $223.6 million, or 32.8%, year-over-year, driven by lower volumes in North America and internationally due to deteriorating market conditions during the first half of 2020, and the disposition of our pressure vessel manufacturing business in the second quarter of 2019.

Operating profit. Production & Automation Technologies operating profit decreased $745.1 million year-over-year primarily driven by goodwill and long-lived asset impairment charges of $616.3 million and $41.0 million, respectively, in the first quarter of 2020. Excluding impairment charges, operating profit decreased $89.6 million, primarily due to lower sales volume, an increase in depreciation and amortization expense of $17.2 million primarily related to a change in salvage value estimate for certain of our leased assets, and increased restructuring expense and other related charges of $3.7 million, partially offset by decreased environmental costs of $2.0 million.

Drilling Technologies
 
 
Three Months Ended September 30,
 
Change
(dollars in thousands)
 
2020
 
2019
 
$
 
%
Revenue
 
$
15,715

 
$
54,877

 
(39,162
)
 
(71.4
)%
Operating profit (loss)
 
(5,127
)
 
13,797

 
(18,924
)
 
(137.2
)%
Operating profit margin
 
(32.6
)%
 
25.1
%
 
 
 
(5770) bps.

 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
1,936

 
$
2,244

 
(308
)
 
(13.7
)%
Restructuring and other related charges
 

 
526

 
(526
)
 
(100.0
)%

Revenue. Drilling Technologies revenue decreased $39.2 million, or 71.4%, in the third quarter of 2020 compared to the prior year primarily due to a steep decline in U.S. land-based rig count and associated decline in customer spending on drilling activities, which negatively impacted sales volumes of our diamond cutters and diamond bearings products.

Operating profit. Drilling Technologies operating profit decreased $18.9 million in the third quarter of 2020 compared to the prior year period primarily due to lower revenue.


37


 
 
Nine Months Ended
September 30,
 
Change
(dollars in thousands)
 
2020
 
2019
 
$
 
%
Revenue
 
$
92,618

 
$
202,764

 
(110,146
)
 
(54.3
)%
Operating profit
 
2,421

 
64,853

 
(62,432
)
 
(96.3
)%
Operating profit margin
 
2.6
%
 
32.0
%
 
 
 
(2940) bps.

 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
6,045

 
7,079

 
(1,034
)
 
(14.6
)%
Restructuring and other related charges
 
5,521

 
526

 
4,995

 
*


Revenue. Drilling Technologies revenue decreased $110.1 million, or 54.3%, year-over-year primarily due to a steep decline in U.S. land-based rig count and associated decline in customer spending on drilling activities, which negatively impacted sales volumes of our diamond cutters and diamond bearings products.

Operating profit. Drilling Technologies operating profit decreased $62.4 million year-over-year due to lower revenue and increased restructuring charges of $5.0 million associated with employee severance and related benefits, partially offset by productivity savings.

Reservoir Chemical Technologies
(dollars in thousands)
 
Three Months Ended September 30, 2020
Nine Months Ended September 30, 2020 (1)
Revenue
 
$
21,264

$
30,570

Operating loss
 
(3,819
)
(6,630
)
Operating loss margin
 
(18.0
)%
(21.7
)%
 
 
 
 
Depreciation and amortization
 
$
1,923

$
4,141

______________________
(1) The results of operations of the Reservoir Chemical Technologies segment have been reflected in the table above from the closing date of the Merger through September 30, 2020.


Revenue. Reservoir Chemical Technologies revenue is primarily comprised of the sale of specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs to service and equipment companies that support global E&P companies. Revenue was $21.3 million for the period. Reservoir Chemical Technologies products are sensitive to changes in its customers’ capital expenditure budgets as they relate closely to the exploration and development of new oil and natural gas reserves. This exploration and development activity is affected by trends in oil and natural gas prices and its customers’ corresponding levels of drilling activity, capital investment and well development.

Operating profit. Reservoir Chemical Technologies generated operating loss of $3.8 million in the third quarter of 2020, which includes depreciation and amortization expense of $1.9 million. Reservoir Chemical Technologies generated operating loss of $6.6 million for the nine months of 2020, which includes depreciation and amortization expense of $4.1 million and an increase in cost of goods sold related to the step-up of inventory as part of the purchase price allocation of $0.5 million.

CAPITAL RESOURCES AND LIQUIDITY

Overview

At September 30, 2020, we had cash and cash equivalent balances of $171.5 million for the primary purpose of working capital and operational support needs. During the second quarter, in order to ensure appropriate liquidity as a result of the industry downturn, the negative business impacts of COVID-19, and to have sufficient funds to extinguish merger-related transaction expenses, we borrowed $125 million against our revolving credit facility. As a result of ongoing robust cash generation throughout the second and third quarters, the Company was able to fully repay the $125 million borrowing during the second quarter as well as an additional $82 million during the third quarter.


38


All of our cash held outside the United States could be repatriated; however, we have not provided for foreign withholding taxes on our undistributed foreign earnings from jurisdictions which impose such taxes since we have determined that such earnings are indefinitely reinvested in those jurisdictions.

Our primary source of cash is from operating activities. We have historically generated, and expect to continue to generate, positive cash flow from operations. Cash generated from operations is generally allocated to working capital requirements, investments in facilities and systems, acquisitions that create value with add-on capabilities that broaden our existing businesses and overall growth strategy, and debt repayments.

At September 30, 2020, we had a long-term debt balance of $989.7 million, net of the current portion of long-term debt of $31.5 million, primarily consisting of our term loan due 2027 with a principal amount of $530.3 million, our senior notes due in 2026 with a principal amount of $300.0 million, and our term loan due in 2025 with a principal amount of $190.0 million. We also have access to a revolving credit facility which expires in May of 2023, which had an unused capacity of $355.4 million at September 30, 2020.

Outlook

We expect to generate our liquidity and capital resources through operations and, when needed, through our revolving credit facility. The volatility in credit, equity and commodity markets resulting from current market conditions can create uncertainty for our businesses. However, the Company believes, based on our current financial condition and current expectations of future market conditions, that we will meet our short- and long-term needs with a combination of cash on hand, cash generated from operations, our use of our revolving credit facility and access to capital markets.

Given the uncertainty created by the lack of visibility of future operating conditions in the current market environment and over the remainder of the year, we are restricting our capital expenditures to maintenance requirements and integration related investments only. We expect our full year 2020 capital expenditures, combined with investment in leased assets in the net cash from operating activities section of our consolidated statement of cash flows, to be between $50 to $55 million.

Cash Flows
 
Nine Months Ended September 30,
(in thousands)
2020
 
2019
Cash provided by operating activities
$
189,432

 
$
123,390

Cash provided by (used in) investing activities
34,714

 
(43,329
)
Cash used in financing activities
(93,445
)
 
(80,949
)
Effect of exchange rate changes on cash and cash equivalents
5,471

 
(317
)
Net increase (decrease) in cash and cash equivalents
$
136,172

 
$
(1,205
)

Operating Activities

Cash provided by operating activities in the nine months ended September 30, 2020 increased $66.0 million compared to 2019. The increase in cash provided by operating activities was primarily driven by increases from changes in our operating assets and liabilities in 2020 as compared to 2019, primarily due to an increase in cash received related to the collection of trade receivables and a reduction in our cash outflows for inventory procurement and cash outflows on leased assets due to strict adherence to cost and capital discipline. Partially offsetting the increase in cash provided by operating cash flows was lower net income, adjusted for non-cash items, and merger related acquisition and integration costs incurred during the period.

Expenditures for assets that are placed into our lease asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows.  All other capitalizable expenditures for assets that are placed into our lease asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

Investing Activities

Cash provided by investing activities was $34.7 million for the nine months ended September 30, 2020, and was primarily comprised of cash acquired in the merger with legacy ChampionX of $57.6 million and $9.3 million of cash proceeds on sale of fixed assets, partially offset by capital expenditures of $32.2 million.

39



Cash used in investing activities was $43.3 million for the nine months ended September 30, 2019 and was primarily comprised of capital expenditures of $31.6 million, a $12.5 million payment to acquire a business comprising certain assets used in the manufacturing of downhole monitoring systems, and a $2.2 million payment related to the sale of our pressure vessel manufacturing business in our Production & Automation Technologies segment, partially offset by $3.0 million of cash proceeds from the sale of fixed assets.

Financing Activities

Cash used in financing activities of $93.4 million for the nine months ended September 30, 2020, was primarily the result of repayments totaling $81.7 million on our Term Loan Facilities, $4.4 million in debt issuance costs related to the amendment of the credit agreement, as discussed in Note 6—Debt to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, $4.5 million of payments of finance lease obligations, and a distribution of $2.2 million to one of our non-controlling interests. Net borrowings under our revolving credit facility totaled zero in 2020 as we borrowed and fully repaid the borrowing within the same period.

Cash used in financing activities of $80.9 million for the nine months ended September 30, 2019, was primarily the result of $111.5 million of debt repayment on the principal balance of our term loan and payments totaling $4.1 million for finance lease obligations, partially offset by proceeds on long-term debt of $36.5 million.

Long-term Debt

Senior Notes

Refer to Note 10Debt, included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2019, for information related to our Senior Notes, which are fully and unconditionally guaranteed by certain 100-percent-owned subsidiaries (the “Guarantors”) of ChampionX on a joint and several basis. On June 18, 2020, the wholly-owned subsidiaries of legacy ChampionX that guarantee the 2018 Credit Facility and the 2020 Term Loan Facility, delivered a Supplemental Indenture to join as guarantors of the senior notes.

The Senior Notes indenture restricts the ability of the Guarantors to pay dividends or other distributions, make loans or advances, or sell, lease or otherwise transfer property and other assets to certain restricted subsidiaries or the Parent.
As part of the Senior Notes indenture, a guarantee of the senior notes by ChampionX or a Guarantor is subject to release in the following circumstances:

the sale, exchange or transfer (by merger or otherwise) of (i) the capital stock of the Guarantor after which the Guarantor is no longer a restricted subsidiary or (ii) all or substantially all of the assets of such Guarantor made in a manner not in violation of the indenture;
the release or discharge of the guarantee by, or direction obligation of, such Guarantor with respect to the Senior Credit Facilities or capital markets debt securities that resulted in the creation of such guarantee, except a discharge by or as a result of payment under such guarantee;
the designation of the subsidiary as an unrestricted subsidiary under the indenture;
the legal defeasance or covenant defeasance of the Senior Notes in accordance with the terms of the indenture;
the merger or consolidation of any Guarantor with and into the Issuer or another Guarantor that is the surviving person in such merger or consolidation, or upon the liquidation of such Guarantor following the transfer of all its assets to the Parent or another Guarantor; or
an amendment of the Senior Note indenture agreement.

The obligations of each Guarantor under its note guarantee are limited as necessary to prevent such note guarantee from constituting a fraudulent conveyance under applicable law.

The following summarized financial information presents the Parent and Guarantors (collectively and together with the Parent, the “Obligor Group”) on a combined basis:

40


Condensed Combined Statement of Loss of the Obligor Group
(dollars in thousands)
 
Nine Months Ended September 30, 2020
Total Revenue
 
$
1,113,381

Cost of goods and services
 
882,034

Selling, general and administrative expense
 
318,327

Goodwill impairment
 
(396,017
)
Long-lived asset impairment
 
(40,980
)
Loss before income taxes
 
(559,541
)
Net loss
 
$
(533,277
)

Condensed Combined Balance Sheets of the Obligor Group
(dollars in thousands)
 
September 30, 2020
 
December 31, 2019
Current assets:
 
 
 
 
Current assets
 
$
1,264,872

 
$
419,692

Non-current assets:
 
 
 
 
Goodwill
 
611,223

 
639,280

Advances due from affiliates
 
17,421

 
18,534

Other non-current assets
 
1,230,457

 
430,553

Total assets
 
$
3,123,973

 
$
1,508,059

 
 
 
 
 
Current liabilities:
 
 
 
 
Current liabilities
 
$
652,004

 
$
173,372

Non-current liabilities:
 
 
 
 
Advances due to affiliates
 
91,686

 
87,682

Other non-current liabilities
 
1,279,455

 
664,581

Total liabilities
 
$
2,023,145

 
$
925,635


Senior Secured Credit Facilities

In May 2018, we entered into a credit agreement (“credit agreement”) governing the terms of our senior secured credit facilities, consisting of (i) a seven-year senior secured term loan B facility (“term loan facility”) and (ii) a five-year senior secured revolving credit facility (“revolving credit facility,” and together with the term loan facility, the “senior secured credit facilities”). Refer to Note 10Debt included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2019, for additional information related to our senior secured credit facilities.

On February 14, 2020, we amended our credit agreement, which (i) provides for the incurrence of an additional $150 million of revolving commitments under the amended credit agreement, upon consummation of the Merger, (ii) permits the consummation of the Merger and the incurrence of a senior secured term loan facility in an aggregate amount up to $537 million by ChampionX, and (iii) continues to provide that all obligations under the amended agreement continue to be guaranteed by certain of our wholly-owned U.S. subsidiaries.
During the nine months ended September 30, 2020, we made a $75.0 million payment on our 2018 Term Loan Facility and amortization payments of $6.7 million on the 2020 Term Loan Facility.


41


Revolving Credit Facility

A summary of our revolving credit facility at September 30, 2020, was as follows:
(in millions)
Description
Amount
 
Debt
Outstanding
 
Letters
of
Credit
 
Unused Capacity
 
Maturity
Five-year revolving credit facility
$
400.0

 
$

 
$
44.6

 
$
355.4

 
May 2023

Additionally, we have a letter of credit outside of the revolving credit facility of approximately $0.2 million. As of September 30, 2020, we were in compliance with all restrictive covenants under our revolving credit facility.

2020 Term Loan Facility

On June 3, 2020, prior to the closing of the Merger, legacy ChampionX entered into a term loan facility for $537.0 million (“2020 Term Loan Facility”). Proceeds from the 2020 Term Loan Facility were utilized to fund a cash payment of $527.4 million from legacy ChampionX to Ecolab prior to the closing of the Merger. We assumed the 2020 Term Loan Facility upon completion of the Merger, which is fully and unconditionally guaranteed by the Company and certain of its wholly-owned domestic subsidiaries, which also guarantee the obligations under the 2018 Term Loan Facility. The 2020 Term Loan Facility matures at the earlier of (i) June 3, 2027 or (ii) January 30, 2026 in the event the Company’s senior unsecured notes due May 1, 2026 remain outstanding. Amounts outstanding under the 2020 Term Loan Facility bear interest, at the option of the Company, at a rate equal to (a) LIBOR plus 5.0% for eurocurrency rate loans or (b) the highest of (i) the Federal Funds Rate plus 1/2 of 1%, (ii) the “prime rate” quoted by Bank of America, N.A., (iii) LIBOR plus 1.00% and (iv) 1.00%, plus 4.0%. The 2020 Term Loan Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type.

OFF-BALANCE SHEET ARRANGEMENTS

Information related to guarantees is incorporated herein by reference from Note 7—Commitments And Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Note 3—New Accounting Standards to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We may be exposed to certain market risks arising from the use of financial instruments in the ordinary course of business. This risk arises primarily as a result of potential changes in the fair market value of financial instruments due to adverse fluctuations in commodity prices, foreign currency exchange rates, and interest rates as discussed below. We do not use derivative financial instruments where the objective is to generate profits solely from trading activities.

Commodity Price Risk

We use a variety of raw materials, primarily metals and semi-processed or finished components, that are generally available from various sources. Commodity pricing for metals, such as nickel, chrome, molybdenum, vanadium, manganese and steel scrap, fluctuate with the market. As a result, our earnings are exposed to commodity market price fluctuations. Although some cost increases may be recovered through increased prices to customers, we attempt to control such costs through fixed-price contracts with suppliers and various other programs, such as our global supply chain activities.


42





Foreign Currency Risk

We conduct operations around the world in a number of different currencies. Many of our foreign subsidiaries have designated the local currency as their functional currency. Our earnings are therefore subject to change due to fluctuations in foreign currency exchange rates when the earnings in foreign currencies are translated into U.S. dollars. We do not hedge this translation impact on earnings. When transactions are denominated in currencies other than our subsidiaries’ respective functional currencies, both with external parties and intercompany relationships, these transactions result in increased exposure to foreign currency exchange effects. The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. As of September 30, 2020, the amount of gain or loss in the fair value of derivative instruments that would have resulted from a 10 percent increase or decrease in the underlying price of the contracts was not material.

Interest Rate Risk

Our use of fixed- or variable-rate debt directly exposes us to interest rate risk. Fixed-rate debt, such as the senior notes, exposes us to changes in the fair value of our debt due to changes in market interest rates. Fixed-rate debt also exposes us to the risk that we may need to refinance maturing debt with new debt at higher rates, or that we may be obligated to pay rates higher than the current market rate. Variable-rate debt, such as our term loan or borrowings under our revolving credit facility, exposes us to short-term changes in market rates that impact our interest expense.

As of September 30, 2020, we had unhedged variable rate debt of $190.0 million related to our 2018 Term Loan Facility with an interest rate of 2.69%. A hypothetical 10% adverse movement in the interest rate, or 27 basis points, would result in an increase to interest expense of $0.5 million on an annualized basis.

We also had unhedged variable rate debt of $530.3 million related to our 2020 Term Loan Facility with an interest rate of 6.00%. A hypothetical 10% adverse movement in the interest rate, or 60 basis points, would result in an increase to interest expense of $1.9 million. As the 2020 Term Loan Facility was acquired as part of the Merger on June 3, 2020, we have calculated the interest rate sensitivity on the interest expense expected to be incurred for the period subsequent to the Merger date through December 31, 2020.

Fair Value of Financial Instruments

The fair value of our fixed rate long-term debt and variable rate debt is estimated based on quoted market prices or prices quoted from third-party financial institutions. We do not currently intend to enter into any interest rate hedging agreements, but will continue to monitor interest rate exposure. See Note 13—Fair Value Measurements to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further discussion of our financial instruments.

ITEM 4. CONTROLS AND PROCEDURES

With the participation of management, our principal executive officer and principal financial officer carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2020 because of the material weaknesses in internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) described in Item 9A - Controls and Procedures in our Form 10-K for the year ended December 31, 2019.

In conducting management’s evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2020, we have excluded the operations of ChampionX Holding Inc. (“legacy ChampionX”) as permitted by the SEC. As part of our ongoing integration of legacy ChampionX, we continue to incorporate our controls and procedures into legacy ChampionX subsidiaries and to expand our company-wide controls to reflect the risks inherent in an acquisition of this size and complexity. The legacy ChampionX subsidiaries account for approximately 51.1% of our total assets as of September 30, 2020.

Notwithstanding the material weaknesses noted above, our management, including our principal executive officer and principal financial officer, has concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are fairly stated in all material respects in accordance with GAAP for each of the periods presented.
 


43





Remediation Activities

As described in Item 9A - Controls and Procedures in our Form 10-K for the year ended December 31, 2019, we identified
material weaknesses in our internal control over financial reporting. Management, with oversight from the Audit Committee, developed a remediation plan to address the material weaknesses. As part of our remediation plan, we have implemented new and enhanced processes, procedures and controls to address certain control deficiencies that led to the material weaknesses. Specifically, management has:

Reviewed staffing competencies and resource requirements at ESP and within the Artificial Lift business and used the results of our review as part of our overall financial statement risk assessment process.

Made personnel changes, including terminations and hiring of staff for both current and newly created positions, at ESP and within the Artificial Lift business in order to strengthen the control environment and to ensure we have a sufficient complement of resources with an appropriate degree of knowledge, expertise and skills commensurate with our financial statement requirements.

Engaged third party experts to assist management in assessing and designing new and enhanced processes, procedures, and controls, including automation of certain processes and controls, at ESP and within the Artificial Lift business.

Implemented policies, procedures and controls at ESP and within the Artificial Lift business to (i) ensure price and quantity are accurately recorded and supported by agreements with customers as part of the revenue recognition process and (ii) properly calculate and support management’s review and assessment for the valuation of accounts receivable reserves.

Implemented policies, procedures and controls at ESP to (i) ensure manual journal entries are properly prepared and reviewed for accuracy and appropriate supporting documentation and (ii) properly account for inventory transfers and fixed asset deployments and disposals as part of ESP’s leased asset program.

Conducted policies and procedural training for all personnel responsible for the performance of control activities over financial reporting as well as specific training for personnel responsible for control activities associated with manual journal entries, revenue recognition, accounts receivable, inventory and fixed assets at ESP and within the Artificial lift business.

Enhanced and formalized certain elements of our Enterprise Risk Management program, including our review and response to significant business changes, within our risk assessment process.

Implemented controls to ensure proper segregation of duties associated with user access rights to system capabilities within the general ledger, specifically the restriction of a system user’s ability to both prepare and post journal entries.

Changes in Internal Control Over Financial Reporting
Except as described above, there were no changes in internal control over financial reporting identified in the evaluation for the quarter ended September 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

44


PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved in various pending or potential legal actions in the ordinary course of our business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows. See Note 7—Commitments And Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

Information concerning our risk factors is contained in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 and is incorporated by reference herein.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a)
None.
(b)
None.
(c)
None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Iran Threat Reduction and Syria Human Rights Act of 2012
Under the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Securities Exchange Act of 1934, the Company is required to disclose in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with entities or individuals designated pursuant to certain Executive Orders. Disclosure is required even where the activities are conducted outside the U.S. by non-U.S. affiliates in compliance with applicable law, and even if the activities are not covered or prohibited by U.S. law.
As authorized by the U.S. Treasury’s Office of Foreign Assets Control (OFAC), a non-U.S. subsidiary of the Company which is part of legacy ChampionX completed sales of products used for process and water treatment applications in upstream oil and gas production related to the operation of and production from the Rhum gas field off the Scottish coast (Rhum) totaling $0.13 million during the period from July 1, 2020 to September 30, 2020. The net profit before taxes associated with these sales for each period were nominal. Rhum is jointly owned by Serica Energy plc and Iranian Oil Company (U.K.) Limited. Our non-U.S. subsidiary intends to continue the Rhum-related activities, consistent with a specific license obtained from OFAC by its customers, and such activities may require additional disclosure pursuant to the abovementioned statute.

45


ITEM 6. EXHIBITS
 
 
 
Exhibit
No.
 
Exhibit Description
 
 
 
 
 
101.INS*
 
XBRL Instance Document
101.SCH*
 
XBRL Taxonomy Extension Schema Document
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase Document
104*
 
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
 
 
* Filed herewith
** Furnished herewith
† Denotes management contract or compensatory plan or arrangement

46


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CHAMPIONX CORPORATION
 
(Registrant)
 
 
 
 
/s/ ANTOINE MARCOS
 
Antoine Marcos
 
Vice President, Corporate Controller and Chief Accounting Officer
 
(Principal Accounting Officer and a Duly Authorized Officer)
 
 
 
 
Date:
October 30, 2020
 

47
Exhibit


Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Sivasankaran Somasundaram, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:
October 30, 2020
 
/s/ SIVASANKARAN SOMASUNDARAM
 
 
 
 
Sivasankaran Somasundaram
 
 
 
 
President and Chief Executive Officer
 
 
 
 
(Principal Executive Officer)
 


Exhibit


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Jay A. Nutt, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:
October 30, 2020
 
/s/ JAY A. NUTT
 
 
 
 
Jay A. Nutt
 
 
 
 
Senior Vice President and
Chief Financial Officer
 
 
 
 
(Principal Financial Officer)
 


Exhibit


Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002, 18 U.S.C. SECTION 1350


I, Sivasankaran Somasundaram, President and Chief Executive Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:
October 30, 2020
 
/s/ SIVASANKARAN SOMASUNDARAM
 
 
 
 
Sivasankaran Somasundaram
 
 
 
 
President and Chief Executive Officer
 
 
 
 
(Principal Executive Officer)
 


Exhibit


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002, 18 U.S.C. SECTION 1350


I, Jay A. Nutt, Senior Vice President and Chief Financial Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:
October 30, 2020
 
/s/ JAY A. NUTT
 
 
 
 
Jay A. Nutt
 
 
 
 
Senior Vice President and
Chief Financial Officer
 
 
 
 
(Principal Financial Officer)